PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"28414496","Impaired psychomotor function and plasma methadone and levo-alpha-acetylmethadol (LAAM) concentrations in opioid-substitution patients","Newcombe DAL, Somogyi AA, Bochner F, White JM.","Exp Clin Psychopharmacol. 2017 Jun;25(3):223-233. doi: 10.1037/pha0000114. Epub 2017 Apr 17.","Newcombe DAL","Exp Clin Psychopharmacol","2017","2017/04/18","","","10.1037/pha0000114"
"24957634","Maintenance treatments for opiate -dependent adolescents","Minozzi S, Amato L, Bellisario C, Davoli M.","Cochrane Database Syst Rev. 2014 Jun 24;(6):CD007210. doi: 10.1002/14651858.CD007210.pub3.","Minozzi S","Cochrane Database Syst Rev","2014","2014/06/25","","","10.1002/14651858.CD007210.pub3"
"24935116","Automated radiochemical synthesis and biodistribution of [¹¹C]l-α-acetylmethadol ([¹¹C]LAAM)","Sai KK, Fan J, Tu Z, Zerkel P, Mach RH, Kharasch ED.","Appl Radiat Isot. 2014 Sep;91:135-40. doi: 10.1016/j.apradiso.2014.05.019. Epub 2014 Jun 2.","Sai KK","Appl Radiat Isot","2014","2014/06/18","PMC4384447","NIHMS662051","10.1016/j.apradiso.2014.05.019"
"24076207","Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration","Hamilton KL, Harris AC, Gewirtz JC.","Brain Res. 2013 Nov 13;1538:73-82. doi: 10.1016/j.brainres.2013.09.026. Epub 2013 Sep 26.","Hamilton KL","Brain Res","2013","2013/10/01","PMC4053187","NIHMS532195","10.1016/j.brainres.2013.09.026"
"23093298","[Accidental levomethadone intoxication in a palliative patient]","Michel-Lauter B, Maier C, Schwarzer A.","Schmerz. 2012 Dec;26(6):721-3. doi: 10.1007/s00482-012-1229-2.","Michel-Lauter B","Schmerz","2012","2012/10/25","","","10.1007/s00482-012-1229-2"
"22263711","Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime","Gryczynski J, Kinlock TW, Kelly SM, O'Grady KE, Gordon MS, Schwartz RP.","Subst Abus. 2012;33(1):30-9. doi: 10.1080/08897077.2011.616816.","Gryczynski J","Subst Abus","2012","2012/01/24","","","10.1080/08897077.2011.616816"
"22021567","Opioids, QTc prolongation, and torsades","Kurt TL.","J Clin Pharmacol. 2012 Oct;52(10):1614. doi: 10.1177/0091270011422816. Epub 2011 Oct 21.","Kurt TL","J Clin Pharmacol","2012","2011/10/25","","","10.1177/0091270011422816"
"20667673","Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence","Gray TR, Dams R, Choo RE, Jones HE, Huestis MA.","Forensic Sci Int. 2011 Mar 20;206(1-3):98-102. doi: 10.1016/j.forsciint.2010.06.031. Epub 2010 Jul 27.","Gray TR","Forensic Sci Int","2011","2010/07/30","PMC3012134","NIHMS226118","10.1016/j.forsciint.2010.06.031"
"20616264","No opiate substitutes for the masses of IDUs","Cohen J.","Science. 2010 Jul 9;329(5988):165-7. doi: 10.1126/science.329.5988.165.","Cohen J","Science","2010","2010/07/10","","","10.1126/science.329.5988.165"
"20163389","Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis","Mancino MJ, McGaugh J, Feldman Z, Poling J, Oliveto A.","Am J Addict. 2010 Mar-Apr;19(2):169-77. doi: 10.1111/j.1521-0391.2009.00025.x.","Mancino MJ","Am J Addict","2010","2010/02/19","PMC3472706","NIHMS393270","10.1111/j.1521-0391.2009.00025.x"
"19910741","Levomethadone is poorly removed by the molecular adsorbents recirculating system","Czock D, Keller F, Hameister J, Tiefenbach B, Mitzner S.","J Clin Psychopharmacol. 2009 Dec;29(6):622-4. doi: 10.1097/JCP.0b013e3181c28957.","Czock D","J Clin Psychopharmacol","2009","2009/11/14","","","10.1097/JCP.0b013e3181c28957"
"19370679","Maintenance treatments for opiate dependent adolescent","Minozzi S, Amato L, Davoli M.","Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007210. doi: 10.1002/14651858.CD007210.pub2.","Minozzi S","Cochrane Database Syst Rev","2009","2009/04/17","","","10.1002/14651858.CD007210.pub2"
"19258204","Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial","Wieneke H, Conrads H, Wolstein J, Breuckmann F, Gastpar M, Erbel R, Scherbaum N.","Eur J Med Res. 2009 Jan 28;14(1):7-12. doi: 10.1186/2047-783x-14-1-7.","Wieneke H","Eur J Med Res","2009","2009/03/05","PMC3352205","","10.1186/2047-783x-14-1-7"
"19171177","Behavioral and degeneration changes in the basal forebrain systems of aged rats: a quantitative study in the region of the basal forebrain after levo-acetyl-carnitine treatments assessed by Abercrombie estimation","Freddi R, Duca P, Gritti I, Mariotti M, Vertemati M.","Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):419-26. doi: 10.1016/j.pnpbp.2008.12.021. Epub 2009 Jan 7.","Freddi R","Prog Neuropsychopharmacol Biol Psychiatry","2009","2009/01/28","","","10.1016/j.pnpbp.2008.12.021"
"19153939","A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction","Wolstein J, Gastpar M, Finkbeiner T, Heinrich C, Heitkamp R, Poehlke T, Scherbaum N.","Pharmacopsychiatry. 2009 Jan;42(1):1-8. doi: 10.1055/s-0028-1083818. Epub 2009 Jan 19.","Wolstein J","Pharmacopsychiatry","2009","2009/01/21","","","10.1055/s-0028-1083818"
"19023658","Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior","Anglin MD, Conner BT, Annon JJ, Longshore D.","J Behav Health Serv Res. 2009 Apr;36(2):267-82. doi: 10.1007/s11414-008-9155-x. Epub 2008 Nov 21.","Anglin MD","J Behav Health Serv Res","2009","2008/11/22","","","10.1007/s11414-008-9155-x"
"18770043","Effect of religiosity and spirituality on drug treatment outcomes","Conner BT, Anglin MD, Annon J, Longshore D.","J Behav Health Serv Res. 2009 Apr;36(2):189-98. doi: 10.1007/s11414-008-9145-z. Epub 2008 Sep 3.","Conner BT","J Behav Health Serv Res","2009","2008/09/05","PMC2693037","NIHMS103639","10.1007/s11414-008-9145-z"
"18585405","Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis","Chopra MP, Feldman Z, Mancino MJ, Oliveto A.","Pharmacol Biochem Behav. 2008 Oct;90(4):787-96. doi: 10.1016/j.pbb.2008.05.023.","Chopra MP","Pharmacol Biochem Behav","2008","2008/07/01","PMC2577173","NIHMS64784","10.1016/j.pbb.2008.05.023"
"18262500","Prenatal opiate exposure impairs radial arm maze performance and reduces levels of BDNF precursor following training","Schrott LM, Franklin L', Serrano PA.","Brain Res. 2008 Mar 10;1198:132-40. doi: 10.1016/j.brainres.2008.01.020. Epub 2008 Jan 18.","Schrott LM","Brain Res","2008","2008/02/12","PMC2696491","NIHMS42256","10.1016/j.brainres.2008.01.020"
"18071169","QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial","Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC.","Arch Intern Med. 2007 Dec 10;167(22):2469-75. doi: 10.1001/archinte.167.22.2469.","Wedam EF","Arch Intern Med","2007","2007/12/12","","","10.1001/archinte.167.22.2469"
"17764707","Self administration of cocaine in monkeys receiving LAAM acutely or chronically","Gerak LR, Galici R, France CP.","Physiol Behav. 2008 Jan 28;93(1-2):20-6. doi: 10.1016/j.physbeh.2007.07.008. Epub 2007 Jul 28.","Gerak LR","Physiol Behav","2008","2007/09/04","PMC2700744","NIHMS38663","10.1016/j.physbeh.2007.07.008"
"17697277","Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status","Anglin MD, Conner BT, Annon J, Longshore D.","Addiction. 2007 Sep;102(9):1432-42. doi: 10.1111/j.1360-0443.2007.01935.x.","Anglin MD","Addiction","2007","2007/08/19","","","10.1111/j.1360-0443.2007.01935.x"
"17697269","Can LAAM, like Lazarus, come back from the dead?","Jaffe JH.","Addiction. 2007 Sep;102(9):1342-3. doi: 10.1111/j.1360-0443.2007.01976.x.","Jaffe JH","Addiction","2007","2007/08/19","","","10.1111/j.1360-0443.2007.01976.x"
"17690563","In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites","Crettol S, Digon P, Golay KP, Brawand M, Eap CB.","Pharmacology. 2007;80(4):304-11. doi: 10.1159/000107104. Epub 2007 Aug 9.","Crettol S","Pharmacology","2007","2007/08/11","","","10.1159/000107104"
"17588493","Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services","Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN.","J Subst Abuse Treat. 2007 Jul;33(1):85-90. doi: 10.1016/j.jsat.2006.11.003. Epub 2007 Jan 9.","Whitley SD","J Subst Abuse Treat","2007","2007/06/26","","","10.1016/j.jsat.2006.11.003"
"17401437","NO counterbalances HO-1 overexpression-induced acceleration of hepatocyte proliferation in mice","Schuett H, Eipel C, Maletzki C, Menger MD, Vollmar B.","Lab Invest. 2007 Jun;87(6):602-12. doi: 10.1038/labinvest.3700548. Epub 2007 Apr 2.","Schuett H","Lab Invest","2007","2007/04/03","","","10.1038/labinvest.3700548"
"17286334","Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems","Trafton JA, Tracy SW, Oliva EM, Humphreys K.","J Stud Alcohol Drugs. 2007 Mar;68(2):165-72. doi: 10.15288/jsad.2007.68.165.","Trafton JA","J Stud Alcohol Drugs","2007","2007/02/09","","","10.15288/jsad.2007.68.165"
"17196563","Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta","Hamilton KL, Franklin L', Roy S, Schrott LM.","Brain Res. 2007 Feb 16;1133(1):92-9. doi: 10.1016/j.brainres.2006.11.044. Epub 2006 Dec 28.","Hamilton KL","Brain Res","2007","2007/01/02","PMC2701894","NIHMS17786","10.1016/j.brainres.2006.11.044"
"17001553","Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel","Nekhayeva IA, Nanovskaya TN, Hankins GD, Ahmed MS.","Am J Perinatol. 2006 Oct;23(7):423-30. doi: 10.1055/s-2006-951301. Epub 2006 Sep 25.","Nekhayeva IA","Am J Perinatol","2006","2006/09/27","","","10.1055/s-2006-951301"
"16919747","HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone","Lott DC, Strain EC, Brooner RK, Bigelow GE, Johnson RE.","J Subst Abuse Treat. 2006 Sep;31(2):187-94. doi: 10.1016/j.jsat.2006.04.005. Epub 2006 Jul 18.","Lott DC","J Subst Abuse Treat","2006","2006/08/22","","","10.1016/j.jsat.2006.04.005"
"16859402","Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence","Maas B, Kerr T, Fairbairn N, Montaner J, Wood E.","Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):533-43. doi: 10.1517/17425255.2.4.533.","Maas B","Expert Opin Drug Metab Toxicol","2006","2006/07/25","","","10.1517/17425255.2.4.533"
"16687365","A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement program","Reid MS, Angrist B, Baker SA, O'leary S, Stone J, Schwartz M, Leiderman D, Montgomery A, Elkashef A, Majewska D, Robinson J, Rotrosen J.","Subst Abus. 2005 Jun;26(2):5-14. doi: 10.1300/j465v26n02_02.","Reid MS","Subst Abus","2005","2006/05/12","","","10.1300/j465v26n02_02"
"16616162","Effect of opioid substitution therapy on alcohol metabolism","Clark NC, Dietze P, Lenné MG, Redman JR.","J Subst Abuse Treat. 2006 Apr;30(3):191-6. doi: 10.1016/j.jsat.2005.11.010.","Clark NC","J Subst Abuse Treat","2006","2006/04/18","","","10.1016/j.jsat.2005.11.010"
"16487227","Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids","Morrish GA, Foster DJ, Somogyi AA.","Br J Clin Pharmacol. 2006 Mar;61(3):326-35. doi: 10.1111/j.1365-2125.2005.02573.x.","Morrish GA","Br J Clin Pharmacol","2006","2006/02/21","PMC1885024","","10.1111/j.1365-2125.2005.02573.x"
"16449090","Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine","McCance-Katz EF, Rainey PM, Smith P, Morse GD, Friedland G, Boyarsky B, Gourevitch M, Jatlow P.","Am J Addict. 2006 Jan-Feb;15(1):23-34. doi: 10.1080/10550490500419029.","McCance-Katz EF","Am J Addict","2006","2006/02/02","","","10.1080/10550490500419029"
"16384657","Predictors of retention in methadone programs: a signal detection analysis","Villafranca SW, McKellar JD, Trafton JA, Humphreys K.","Drug Alcohol Depend. 2006 Jul 27;83(3):218-24. doi: 10.1016/j.drugalcdep.2005.11.020. Epub 2005 Dec 27.","Villafranca SW","Drug Alcohol Depend","2006","2005/12/31","","","10.1016/j.drugalcdep.2005.11.020"
"16366759","Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence","Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE.","Exp Clin Psychopharmacol. 2005 Nov;13(4):293-302. doi: 10.1037/1064-1297.13.4.293.","Marsch LA","Exp Clin Psychopharmacol","2005","2005/12/22","","","10.1037/1064-1297.13.4.293"
"16364566","Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial","Strathdee SA, Ricketts EP, Huettner S, Cornelius L, Bishai D, Havens JR, Beilenson P, Rapp C, Lloyd JJ, Latkin CA.","Drug Alcohol Depend. 2006 Jul 27;83(3):225-32. doi: 10.1016/j.drugalcdep.2005.11.015. Epub 2005 Dec 20.","Strathdee SA","Drug Alcohol Depend","2006","2005/12/21","PMC2196224","NIHMS36559","10.1016/j.drugalcdep.2005.11.015"
"16299549","Blood-brain equilibration kinetics of levo-alpha-acetyl-methadol using a chronically instrumented sheep preparation","Foster DJ, Jensen ML, Upton RN, Somogyi AA, Grant C, Martinez A.","Br J Pharmacol. 2006 Jan;147(2):209-17. doi: 10.1038/sj.bjp.0706470.","Foster DJ","Br J Pharmacol","2006","2005/11/22","PMC1615857","","10.1038/sj.bjp.0706470"
"16161728","A novel opioid maintenance program for prisoners: report of post-release outcomes","Kinlock TW, Battjes RJ, Schwartz RP; MTC Project Team.","Am J Drug Alcohol Abuse. 2005;31(3):433-54. doi: 10.1081/ada-200056804.","Kinlock TW","Am J Drug Alcohol Abuse","2005","2005/09/16","","","10.1081/ada-200056804"
"16055764","Medication development for addictive disorders: the state of the science","Vocci FJ, Acri J, Elkashef A.","Am J Psychiatry. 2005 Aug;162(8):1432-40. doi: 10.1176/appi.ajp.162.8.1432.","Vocci FJ","Am J Psychiatry","2005","2005/08/02","","","10.1176/appi.ajp.162.8.1432"
"16042643","Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use","Longshore D, Annon J, Anglin MD, Rawson RA.","Addiction. 2005 Aug;100(8):1131-9. doi: 10.1111/j.1360-0443.2005.01122.x.","Longshore D","Addiction","2005","2005/07/27","","","10.1111/j.1360-0443.2005.01122.x"
"16019973","Males and females differ in response to opioid agonist medications","Jones HE, Fitzgerald H, Johnson RE.","Am J Addict. 2005 May-Jun;14(3):223-33. doi: 10.1080/10550490590949569.","Jones HE","Am J Addict","2005","2005/07/16","","","10.1080/10550490590949569"
"16002025","Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients","Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR.","Drug Alcohol Depend. 2005 Aug 1;79(2):157-65. doi: 10.1016/j.drugalcdep.2005.01.007.","Oliveto A","Drug Alcohol Depend","2005","2005/07/09","","","10.1016/j.drugalcdep.2005.01.007"
"15966756","Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies","Kharasch ED, Whittington D, Hoffer C, Krudys K, Craig K, Vicini P, Sheffels P, Lalovic B.","Clin Pharmacokinet. 2005;44(7):731-51. doi: 10.2165/00003088-200544070-00005.","Kharasch ED","Clin Pharmacokinet","2005","2005/06/22","","","10.2165/00003088-200544070-00005"
"15946731","Cross-tolerance and mu agonist efficacy in pigeons treated with LAAM or buprenorphine","Galici R, McMahon LR, France CP.","Pharmacol Biochem Behav. 2005 Jul;81(3):626-34. doi: 10.1016/j.pbb.2005.05.003.","Galici R","Pharmacol Biochem Behav","2005","2005/06/11","","","10.1016/j.pbb.2005.05.003"
"15882404","Anti-nociceptive efficacy of carprofen, levomethadone and buprenorphine for pain relief in cats following major orthopaedic surgery","Möllenhoff A, Nolte I, Kramer S.","J Vet Med A Physiol Pathol Clin Med. 2005 May;52(4):186-98. doi: 10.1111/j.1439-0442.2005.00710.x.","Möllenhoff A","J Vet Med A Physiol Pathol Clin Med","2005","2005/05/11","","","10.1111/j.1439-0442.2005.00710.x"
"15706138","Monoaminergic drugs and directly observable signs of LAAM withdrawal in rhesus monkeys","Sell SL, McMahon LR, Koek W, France CP.","Behav Pharmacol. 2005 Feb;16(1):53-8. doi: 10.1097/00008877-200502000-00006.","Sell SL","Behav Pharmacol","2005","2005/02/12","","","10.1097/00008877-200502000-00006"
"15681124","HPA axis dysregulation following prenatal opiate exposure and postnatal withdrawal","Hamilton KL, Harris AC, Gewirtz JC, Sparber SB, Schrott LM.","Neurotoxicol Teratol. 2005 Jan-Feb;27(1):95-103. doi: 10.1016/j.ntt.2004.09.004.","Hamilton KL","Neurotoxicol Teratol","2005","2005/02/01","","","10.1016/j.ntt.2004.09.004"
"15380290","Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis","Newcombe DA, Bochner F, White JM, Somogyi AA.","Drug Alcohol Depend. 2004 Oct 5;76(1):63-72. doi: 10.1016/j.drugalcdep.2004.04.004.","Newcombe DA","Drug Alcohol Depend","2004","2004/09/24","","","10.1016/j.drugalcdep.2004.04.004"
"15331122","Suppressed fever and hypersensitivity responses in chicks prenatally exposed to opiates","Schrott LM, Sparber SB.","Brain Behav Immun. 2004 Nov;18(6):515-25. doi: 10.1016/j.bbi.2003.12.006.","Schrott LM","Brain Behav Immun","2004","2004/08/28","","","10.1016/j.bbi.2003.12.006"
"15289792","Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individuals","Moody DE, Walsh SL, Rollins DE, Neff JA, Huang W.","Clin Pharmacol Ther. 2004 Aug;76(2):154-66. doi: 10.1016/j.clpt.2004.04.004.","Moody DE","Clin Pharmacol Ther","2004","2004/08/04","","","10.1016/j.clpt.2004.04.004"
"15279123","Diffusion of substance abuse treatment: will buprenorphine be a success?","Ling W, Cunningham-Rathner J, Rawson R.","J Psychoactive Drugs. 2004 May;Suppl 2:115-7. doi: 10.1080/02791072.2004.10400046.","Ling W","J Psychoactive Drugs","2004","2004/07/29","","","10.1080/02791072.2004.10400046"
"15204667","Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir","McCance-Katz EF, Rainey PM, Smith P, Morse G, Friedland G, Gourevitch M, Jatlow P.","Am J Addict. 2004 Mar-Apr;13(2):163-80. doi: 10.1080/10550490490436037.","McCance-Katz EF","Am J Addict","2004","2004/06/19","","","10.1080/10550490490436037"
"15113550","Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometry","Eap CB, Bouchoux G, Scherbaum N, Gastpar M, Powell Golay K, Baumann P.","J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jun 5;805(1):141-6. doi: 10.1016/j.jchromb.2004.02.034.","Eap CB","J Chromatogr B Analyt Technol Biomed Life Sci","2004","2004/04/29","","","10.1016/j.jchromb.2004.02.034"
"15104241","N-demethylation of levo-alpha-acetylmethadol by human placental aromatase","Deshmukh SV, Nanovskaya TN, Hankins GD, Ahmed MS.","Biochem Pharmacol. 2004 Mar 1;67(5):885-92. doi: 10.1016/j.bcp.2003.10.007.","Deshmukh SV","Biochem Pharmacol","2004","2004/04/24","","","10.1016/j.bcp.2003.10.007"
"15049750","Comments on Ritter et al.'s report of a comparative trial of LAAM and methadone maintenance","Caplehorn J.","Addiction. 2004 Apr;99(4):509-10; author reply 510-1. doi: 10.1111/j.1360-0443.2004.00682.x.","Caplehorn J","Addiction","2004","2004/03/31","","","10.1111/j.1360-0443.2004.00682.x"
"15049745","Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)","Digiusto E, Shakeshaft A, Ritter A, O'Brien S, Mattick RP; NEPOD Research Group.","Addiction. 2004 Apr;99(4):450-60. doi: 10.1111/j.1360-0443.2004.00654.x.","Digiusto E","Addiction","2004","2004/03/31","","","10.1111/j.1360-0443.2004.00654.x"
"14955776","Actions and addiction liabilities of alpha-acetyl-methadols in man","FRASER HF, ISBELL H.","J Pharmacol Exp Ther. 1952 Aug;105(4):458-65.","FRASER HF","J Pharmacol Exp Ther","1952","1952/08/01","","",""
"14928223","Analgesic activity and toxic effects of acetylmethadol isomers in man","KEATS AS, BEECHER HK.","J Pharmacol Exp Ther. 1952 Jun;105(2):210-5.","KEATS AS","J Pharmacol Exp Ther","1952","1952/06/01","","",""
"14769623","Treating opioid dependence. Growing implications for primary care","Krantz MJ, Mehler PS.","Arch Intern Med. 2004 Feb 9;164(3):277-88. doi: 10.1001/archinte.164.3.277.","Krantz MJ","Arch Intern Med","2004","2004/02/11","","","10.1001/archinte.164.3.277"
"14687956","Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment","Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K.","Drug Alcohol Depend. 2004 Jan 7;73(1):23-31. doi: 10.1016/j.drugalcdep.2003.08.007.","Trafton JA","Drug Alcohol Depend","2004","2003/12/23","","","10.1016/j.drugalcdep.2003.08.007"
"14643944","The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving","Lenné MG, Dietze P, Rumbold GR, Redman JR, Triggs TJ.","Drug Alcohol Depend. 2003 Dec 11;72(3):271-8. doi: 10.1016/j.drugalcdep.2003.08.002.","Lenné MG","Drug Alcohol Depend","2003","2003/12/04","","","10.1016/j.drugalcdep.2003.08.002"
"14616187","A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia","Ritter AJ, Lintzeris N, Clark N, Kutin JJ, Bammer G, Panjari M.","Addiction. 2003 Nov;98(11):1605-13. doi: 10.1046/j.1360-0443.2003.00529.x.","Ritter AJ","Addiction","2003","2003/11/18","","","10.1046/j.1360-0443.2003.00529.x"
"14556394","[Substitutions therapy of opiate addiction in Denmark]","Ishøy T, Iversen C.","Ugeskr Laeger. 2003 Sep 15;165(38):3620-3.","Ishøy T","Ugeskr Laeger","2003","2003/10/15","","",""
"13357375","Modification of morphine, l-isomethadone, dl-alpha acetylmethadol, and n-allylnormorphine constipation by hydergine","DAVID NA, VAN ARSDEL WC 3rd.","J Am Pharm Assoc Am Pharm Assoc. 1956 Sep;45(9):645-9. doi: 10.1002/jps.3030450918.","DAVID NA","J Am Pharm Assoc Am Pharm Assoc","1956","1956/09/01","","","10.1002/jps.3030450918"
"13318970","Control of chronic pain by DL-alpha acetylmethadol","DAVID NA, SEMLER HJ, BURGNER PR.","J Am Med Assoc. 1956 Jun 16;161(7):599-603. doi: 10.1001/jama.1956.02970070031008.","DAVID NA","J Am Med Assoc","1956","1956/06/16","","","10.1001/jama.1956.02970070031008"
"13143472","The fate of the optical isomers of alpha-acetylmethadol","SUNG CY, WAY EL.","J Pharmacol Exp Ther. 1954 Mar;110(3):260-70.","SUNG CY","J Pharmacol Exp Ther","1954","1954/03/01","","",""
"13118488","Synthetic analgesics: III. Methadols, isomethadols, and their acyl derivatives","LEIMBACH DG, EDDY NB.","J Pharmacol Exp Ther. 1954 Feb;110(2):135-47.","LEIMBACH DG","J Pharmacol Exp Ther","1954","1954/02/01","","",""
"13083012","Addiction potentialities of some methadone analgesics and alpha acetylmethadol as determined by their hyperglycemic responses in rabbits","PHATAK NM, DAVID NA.","Curr Res Anesth Analg. 1953 Jul-Aug;32(4):242-9.","PHATAK NM","Curr Res Anesth Analg","1953","1953/07/01","","",""
"12875273","Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002","Colker AC.","Issue Brief Health Policy Track Serv. 2002 Dec 31:1-6.","Colker AC","Issue Brief Health Policy Track Serv","2002","2003/07/24","","",""
"12857659","Pharmacologic treatments for heroin and cocaine dependence","Kleber HD.","Am J Addict. 2003;12(s2):S5-S18.","Kleber HD","Am J Addict","2003","2003/07/15","","",""
"12766254","Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone","Sell SL, McMahon LR, France CP.","J Pharmacol Exp Ther. 2003 Sep;306(3):1167-73. doi: 10.1124/jpet.103.051425. Epub 2003 May 23.","Sell SL","J Pharmacol Exp Ther","2003","2003/05/27","","","10.1124/jpet.103.051425"
"12703332","Clinical treatment of opioid addiction and dependence","Ling W, Rawson RA, Compton M.","Methods Mol Med. 2003;84:285-95. doi: 10.1385/1-59259-379-8:285.","Ling W","Methods Mol Med","2003","2003/04/22","","","10.1385/1-59259-379-8:285"
"12676878","Transfer of L-alpha-acetylmethadol (LAAM) and L-alpha-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule","Nanovskaya TN, Deshmukh SV, Miles R, Burmaster S, Ahmed MS.","J Pharmacol Exp Ther. 2003 Jul;306(1):205-12. doi: 10.1124/jpet.103.050690. Epub 2003 Apr 3.","Nanovskaya TN","J Pharmacol Exp Ther","2003","2003/04/05","","","10.1124/jpet.103.050690"
"12646332","Feasibility of referring drug users from a needle exchange program into an addiction treatment program: experience with a mobile treatment van and LAAM maintenance","Kuo I, Brady J, Butler C, Schwartz R, Brooner R, Vlahov D, Strathdee SA.","J Subst Abuse Treat. 2003 Jan;24(1):67-74. doi: 10.1016/s0740-5472(02)00343-4.","Kuo I","J Subst Abuse Treat","2003","2003/03/21","","","10.1016/s0740-5472(02)00343-4"
"12498903","Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels","Kang J, Chen XL, Wang H, Rampe D.","Eur J Pharmacol. 2003 Jan 1;458(1-2):25-9. doi: 10.1016/s0014-2999(02)02700-0.","Kang J","Eur J Pharmacol","2003","2002/12/25","","","10.1016/s0014-2999(02)02700-0"
"12486677","Determination of l-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in clinical and in vitro samples using liquid chromatography with electrospray ionization and tandem mass spectrometry","Huang W, Bemis PA, Slawson MH, Moody DE.","J Pharm Sci. 2003 Jan;92(1):10-20. doi: 10.1002/jps.10263.","Huang W","J Pharm Sci","2003","2002/12/18","","","10.1002/jps.10263"
"12438837","Training primary health care professionals to provide buprenorphine and LAAM treatment","Lintzeris N, Ritter A, Dunlop A, Muhleisen P.","Subst Abus. 2002 Dec;23(4):245-54. doi: 10.1080/08897070209511497.","Lintzeris N","Subst Abus","2002","2002/11/20","","","10.1080/08897070209511497"
"12388652","Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents","Katchman AN, McGroary KA, Kilborn MJ, Kornick CA, Manfredi PL, Woosley RL, Ebert SN.","J Pharmacol Exp Ther. 2002 Nov;303(2):688-94. doi: 10.1124/jpet.102.038240.","Katchman AN","J Pharmacol Exp Ther","2002","2002/10/22","","","10.1124/jpet.102.038240"
"12373424","Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats","Newman JL, Vann RE, May EL, Beardsley PM.","Psychopharmacology (Berl). 2002 Oct;164(1):108-14. doi: 10.1007/s00213-002-1198-8. Epub 2002 Aug 9.","Newman JL","Psychopharmacology (Berl)","2002","2002/10/10","","","10.1007/s00213-002-1198-8"
"12235259","Prenatal opiate withdrawal activates the chick embryo hypothalamic pituitary-adrenal axis and dilates vitelline blood vessels via serotonin(2) receptors","Schrott LM, Baumgart MI, Zhang X, Sparber SB.","J Pharmacol Exp Ther. 2002 Oct;303(1):257-64. doi: 10.1124/jpet.102.037044.","Schrott LM","J Pharmacol Exp Ther","2002","2002/09/18","","","10.1124/jpet.102.037044"
"12220607","History and current status of opioid maintenance treatments: blending conference session","Kreek MJ, Vocci FJ.","J Subst Abuse Treat. 2002 Sep;23(2):93-105. doi: 10.1016/s0740-5472(02)00259-3.","Kreek MJ","J Subst Abuse Treat","2002","2002/09/11","","","10.1016/s0740-5472(02)00259-3"
"12094997","The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence","Borg L, Ho A, Wells A, Joseph H, Appel P, Moody D, Kreek MJ.","J Addict Dis. 2002;21(3):13-22. doi: 10.1300/J069v21n03_02.","Borg L","J Addict Dis","2002","2002/07/04","","","10.1300/J069v21n03_02"
"12076441","LAAM maintenance vs methadone maintenance for heroin dependence","Clark N, Lintzeris N, Gijsbers A, Whelan G, Dunlop A, Ritter A, Ling W.","Cochrane Database Syst Rev. 2002;(2):CD002210. doi: 10.1002/14651858.CD002210.","Clark N","Cochrane Database Syst Rev","2002","2002/06/22","","","10.1002/14651858.CD002210"
"12065015","Which substitution pharmacotherapy is most effective in treating opioid dependence?","Gowing LR, Ali RL, White JM.","Med J Aust. 2002 May 20;176(10):493-4.","Gowing LR","Med J Aust","2002","2002/06/18","","",""
"12062776","Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder","Linehan MM, Dimeff LA, Reynolds SK, Comtois KA, Welch SS, Heagerty P, Kivlahan DR.","Drug Alcohol Depend. 2002 Jun 1;67(1):13-26. doi: 10.1016/s0376-8716(02)00011-x.","Linehan MM","Drug Alcohol Depend","2002","2002/06/14","","","10.1016/s0376-8716(02)00011-x"
"12062464","Relationship between LAAM-methadone preference and treatment outcomes","White JM, Danz C, Kneebone J, La Vincente SF, Newcombe DA, Ali RL.","Drug Alcohol Depend. 2002 May 1;66(3):295-301. doi: 10.1016/s0376-8716(02)00007-8.","White JM","Drug Alcohol Depend","2002","2002/06/14","","","10.1016/s0376-8716(02)00007-8"
"12039617","A novel opioid maintenance program for prisoners: preliminary findings","Kinlock TW, Battjes RJ, Schwartz RP; MTC Project Team.","J Subst Abuse Treat. 2002 Apr;22(3):141-7. doi: 10.1016/s0740-5472(02)00226-x.","Kinlock TW","J Subst Abuse Treat","2002","2002/06/01","","","10.1016/s0740-5472(02)00226-x"
"12022632","Developmental toxicity of levo-alpha-acetylmethadol (LAAM) in tolerant rats","York RG, Denny KH, Moody DE, Alburges ME.","Int J Toxicol. 2002 Mar-Apr;21(2):147-59. doi: 10.1080/10915810252866105.","York RG","Int J Toxicol","2002","2002/05/23","","","10.1080/10915810252866105"
"11998586","Med-psych drug-drug interactions update","Armstrong SC, Cozza KL.","Psychosomatics. 2002 Mar-Apr;43(2):169-70. doi: 10.1176/appi.psy.43.2.169.","Armstrong SC","Psychosomatics","2002","2002/05/10","","","10.1176/appi.psy.43.2.169"
"11974198","The alternative therapy","Hicks M.","Nurs Stand. 2000 Jul 26-Aug 1;14(45):18.","Hicks M","Nurs Stand","2000","2002/04/27","","",""
"11897965","Toxicologic aspects of heroin substitution treatment","Cone EJ, Preston KL.","Ther Drug Monit. 2002 Apr;24(2):193-8. doi: 10.1097/00007691-200204000-00001.","Cone EJ","Ther Drug Monit","2002","2002/03/19","","","10.1097/00007691-200204000-00001"
"11841899","Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis","Farré M, Mas A, Torrens M, Moreno V, Camí J.","Drug Alcohol Depend. 2002 Feb 1;65(3):283-90. doi: 10.1016/s0376-8716(01)00171-5.","Farré M","Drug Alcohol Depend","2002","2002/02/14","","","10.1016/s0376-8716(01)00171-5"
"11783744","Effect of opioid dependence pharmacotherapies on zidovudine disposition","McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P.","Am J Addict. 2001 Fall;10(4):296-307.","McCance-Katz EF","Am J Addict","2001","2002/01/11","","",""
"11760927","Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM)","Deamer RL, Wilson DR, Clark DS, Prichard JG.","J Addict Dis. 2001;20(4):7-14. doi: 10.1300/J069v20n04_02.","Deamer RL","J Addict Dis","2001","2002/01/05","","","10.1300/J069v20n04_02"
"11760922","Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon","Stimmel B.","J Addict Dis. 2001;20(4):1-5. doi: 10.1300/J069v20n04_01.","Stimmel B","J Addict Dis","2001","2002/01/05","","","10.1300/J069v20n04_01"
"11531909","Opioid chronopharmacology","Fox AW.","Cephalalgia. 2001 Jul;21(6):708. doi: 10.1046/j.1468-2982.2001.00234.x.","Fox AW","Cephalalgia","2001","2001/09/05","","","10.1046/j.1468-2982.2001.00234.x"
"11515335","[Review of scientific evidence on alternatives to methadone in the psychopharmacologic treatment of opiate dependence]","Iruín A, Aizpurua I, Ruiz de Apodaka J, Zapiraín E, Aizpuru A.","Rev Esp Salud Publica. 2001 May-Jun;75(3):207-19.","Iruín A","Rev Esp Salud Publica","2001","2001/08/23","","",""
"11504799","Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation","Oda Y, Kharasch ED.","J Pharmacol Exp Ther. 2001 Sep;298(3):1021-32.","Oda Y","J Pharmacol Exp Ther","2001","2001/08/16","","",""
"11449919","FDA changes labeling for opiate addiction drug","","AIDS Read. 2001 Jun;11(6):298.","","AIDS Read","2001","2001/07/14","","",""
"11396966","Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4","Neff JA, Moody DE.","Biochem Biophys Res Commun. 2001 Jun 15;284(3):751-6. doi: 10.1006/bbrc.2001.5054.","Neff JA","Biochem Biophys Res Commun","2001","2001/06/09","","","10.1006/bbrc.2001.5054"
"11386912","From the Food and Drug Administration","Schwetz BA.","JAMA. 2001 Jun 6;285(21):2705.","Schwetz BA","JAMA","2001","2001/06/21","","",""
"11259570","Metabolism of levo-alpha-Acetylmethadol (LAAM) by human liver cytochrome P450: involvement of CYP3A4 characterized by atypical kinetics with two binding sites","Oda Y, Kharasch ED.","J Pharmacol Exp Ther. 2001 Apr;297(1):410-22.","Oda Y","J Pharmacol Exp Ther","2001","2001/03/22","","",""
"11210198","Addiction pharmacotherapy 2000: new options, new challenges","Rawson RA, McCann MJ, Hasson AJ, Ling W.","J Psychoactive Drugs. 2000 Oct-Dec;32(4):371-8. doi: 10.1080/02791072.2000.10400238.","Rawson RA","J Psychoactive Drugs","2000","2001/02/24","","","10.1080/02791072.2000.10400238"
"11187226","[New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ]","Petersen H, Skauge L, Svejsø J, Ege PP.","Ugeskr Laeger. 2000 Nov 27;162(48):6553-6.","Petersen H","Ugeskr Laeger","2000","2001/02/24","","",""
"11181502","Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation","Nelson AC, Huang W, Moody DE.","Drug Metab Dispos. 2001 Mar;29(3):319-25.","Nelson AC","Drug Metab Dispos","2001","2001/02/22","","",""
"11064490","Effects of LAAM and methadone utilization in an opiate agonist treatment program","Valdivia JF, Khattak S.","Mt Sinai J Med. 2000 Oct-Nov;67(5-6):398-403.","Valdivia JF","Mt Sinai J Med","2000","2000/11/07","","",""
"11058680","Treating opioid dependence--new data and new opportunities","O'Connor PG.","N Engl J Med. 2000 Nov 2;343(18):1332-4. doi: 10.1056/NEJM200011023431809.","O'Connor PG","N Engl J Med","2000","2000/11/04","","","10.1056/NEJM200011023431809"
"11058673","A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE.","N Engl J Med. 2000 Nov 2;343(18):1290-7. doi: 10.1056/NEJM200011023431802.","Johnson RE","N Engl J Med","2000","2000/11/04","","","10.1056/NEJM200011023431802"
"10911931","Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine","Kreek MJ.","Ann N Y Acad Sci. 2000;909:186-216. doi: 10.1111/j.1749-6632.2000.tb06683.x.","Kreek MJ","Ann N Y Acad Sci","2000","2000/07/27","","","10.1111/j.1749-6632.2000.tb06683.x"
"10877739","Pharmacologic treatment of heroin-dependent patients","O'Connor PG, Fiellin DA.","Ann Intern Med. 2000 Jul 4;133(1):40-54. doi: 10.7326/0003-4819-133-1-200007040-00008.","O'Connor PG","Ann Intern Med","2000","2000/07/06","","","10.7326/0003-4819-133-1-200007040-00008"
"10871309","Chronic l-alpha-acetylmethadol (LAAM) in rhesus monkeys: tolerance and cross-tolerance to the antinociceptive, ventilatory, and rate-decreasing effects of opioids","Brandt MR, France CP.","J Pharmacol Exp Ther. 2000 Jul;294(1):168-78.","Brandt MR","J Pharmacol Exp Ther","2000","2000/06/28","","",""
"10517557","Detection of methadone, LAAM, and their metabolites by methadone immunoassays","Cheever ML, Armendariz GA, Moody DE.","J Anal Toxicol. 1999 Oct;23(6):500-5. doi: 10.1093/jat/23.6.500.","Cheever ML","J Anal Toxicol","1999","1999/10/12","","","10.1093/jat/23.6.500"
"10215673","Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions","Eissenberg T, Stitzer ML, Bigelow GE, Buchhalter AR, Walsh SL.","J Pharmacol Exp Ther. 1999 May;289(2):936-45.","Eissenberg T","J Pharmacol Exp Ther","1999","1999/04/24","","",""
"10193138","Treatment considerations in the opioid dependent patient","Wartenberg AA.","Med Health R I. 1999 Mar;82(3):91-4.","Wartenberg AA","Med Health R I","1999","1999/04/08","","",""
"10023607","Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings","Litten RZ, Allen JP.","J Subst Abuse Treat. 1999 Mar;16(2):105-12. doi: 10.1016/s0740-5472(98)00028-2.","Litten RZ","J Subst Abuse Treat","1999","1999/02/19","","","10.1016/s0740-5472(98)00028-2"
"9864289","Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal","Brandt MR, France CP.","J Pharmacol Exp Ther. 1998 Dec;287(3):1029-37.","Brandt MR","J Pharmacol Exp Ther","1998","1998/12/24","","",""
"9809131","Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study","Oliveto AH, Farren C, Kosten TR.","Am J Addict. 1998 Fall;7(4):272-82.","Oliveto AH","Am J Addict","1998","1998/11/11","","",""
"9789712","Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale","Rosse RB, Johri S, Goel M, Rahman F, Jawor KA, Deutsch SI.","Clin Neuropharmacol. 1998 Sep-Oct;21(5):312-5.","Rosse RB","Clin Neuropharmacol","1998","1998/10/28","","",""
"9707384","Induction with levomethadyl acetate: safety and efficacy","Jones HE, Strain EC, Bigelow GE, Walsh SL, Stitzer ML, Eissenberg T, Johnson RE.","Arch Gen Psychiatry. 1998 Aug;55(8):729-36. doi: 10.1001/archpsyc.55.8.729.","Jones HE","Arch Gen Psychiatry","1998","1998/08/26","","","10.1001/archpsyc.55.8.729"
"9684391","A 3-year progress report on the implementation of LAAM in the United States","Rawson RA, Hasson AL, Huber AM, McCann MJ, Ling W.","Addiction. 1998 Apr;93(4):533-40. doi: 10.1046/j.1360-0443.1998.9345338.x.","Rawson RA","Addiction","1998","1998/07/31","","","10.1046/j.1360-0443.1998.9345338.x"
"9580575","Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance","Houtsmuller EJ, Walsh SL, Schuh KJ, Johnson RE, Stitzer ML, Bigelow GE.","J Pharmacol Exp Ther. 1998 May;285(2):387-96.","Houtsmuller EJ","J Pharmacol Exp Ther","1998","1998/05/15","","",""
"9548895","Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair","Wilkins DG, Valdez AS, Nagasawa PR, Gygi SP, Rollins DE.","J Pharm Sci. 1998 Apr;87(4):435-40. doi: 10.1021/js970360t.","Wilkins DG","J Pharm Sci","1998","1998/04/21","","","10.1021/js970360t"
"9535996","Intravenous and oral l-alpha-acetylmethadol: pharmacodynamics and pharmacokinetics in humans","Walsh SL, Johnson RE, Cone EJ, Bigelow GE.","J Pharmacol Exp Ther. 1998 Apr;285(1):71-82.","Walsh SL","J Pharmacol Exp Ther","1998","1998/05/16","","",""
"9437627","Levo-Alpha Acetyl Methadol (LAAM). Its advantages and drawbacks","Finn P, Wilcock K.","J Subst Abuse Treat. 1997 Nov-Dec;14(6):559-64. doi: 10.1016/s0740-5472(97)00176-1.","Finn P","J Subst Abuse Treat","1997","1998/01/23","","","10.1016/s0740-5472(97)00176-1"
"9398932","Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials","Glanz M, Klawansky S, McAullife W, Chalmers T.","Am J Addict. 1997 Fall;6(4):339-49.","Glanz M","Am J Addict","1997","1997/12/17","","",""
"9394023","The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone","Moody DE, Alburges ME, Parker RJ, Collins JM, Strong JM.","Drug Metab Dispos. 1997 Dec;25(12):1347-53.","Moody DE","Drug Metab Dispos","1997","1998/01/31","","",""
"9353405","l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog","Vaupel DB, Jasinski DR.","J Pharmacol Exp Ther. 1997 Nov;283(2):833-42.","Vaupel DB","J Pharmacol Exp Ther","1997","1997/11/14","","",""
"9323520","Quantitative analysis of l-alpha-acetylmethadol, l-alpha-acetyl-N-normethadol, and l-alpha-acetyl-N,N-dinormethadol in human hair by positive ion chemical ionization mass spectrometry","Wilkins DG, Valdez AS, Krueger GG, Rollins DE.","J Anal Toxicol. 1997 Oct;21(6):420-6. doi: 10.1093/jat/21.6.420.","Wilkins DG","J Anal Toxicol","1997","1997/11/05","","","10.1093/jat/21.6.420"
"9262317","Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys","Brandt MR, Cabansag SR, France CP.","J Pharmacol Exp Ther. 1997 Aug;282(2):574-84.","Brandt MR","J Pharmacol Exp Ther","1997","1997/08/01","","",""
"9200635","Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. A randomized clinical trial","Eissenberg T, Bigelow GE, Strain EC, Walsh SL, Brooner RK, Stitzer ML, Johnson RE.","JAMA. 1997 Jun 25;277(24):1945-51.","Eissenberg T","JAMA","1997","1997/06/25","","",""
"9152388","Changes in sensitivity to the rate-decreasing effects of opioids in pigeons treated acutely or chronically with l-alpha-acetylmethadol","Gerak LR, France CP.","J Pharmacol Exp Ther. 1997 May;281(2):799-809.","Gerak LR","J Pharmacol Exp Ther","1997","1997/05/01","","",""
"8926727","A gas chromatographic-positive ion chemical ionization-mass spectrometric method for the determination of I-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in plasma, urine, and tissue","Moody DE, Crouch DJ, Sakashita CO, Alburges ME, Minear K, Schulthies JE, Foltz RL.","J Anal Toxicol. 1995 Oct;19(6):343-51. doi: 10.1093/jat/19.6.343.","Moody DE","J Anal Toxicol","1995","1995/10/01","","","10.1093/jat/19.6.343"
"8666717","Toxicological evaluation of mu-agonists. Part II: Assessment of toxicity following 30 days of repeated oral dosing of male and female rats with levo-alpha-noracetylmethadol HCl (NorLAAM)","Borzelleca JF, Egle JL Jr, Harris LS, Belleville JA.","J Appl Toxicol. 1995 Sep-Oct;15(5):339-55. doi: 10.1002/jat.2550150503.","Borzelleca JF","J Appl Toxicol","1995","1995/09/01","","","10.1002/jat.2550150503"
"8594167","Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction","Prendergast ML, Grella C, Perry SM, Anglin MD.","J Psychoactive Drugs. 1995 Jul-Sep;27(3):239-47. doi: 10.1080/02791072.1995.10472469.","Prendergast ML","J Psychoactive Drugs","1995","1995/07/01","","","10.1080/02791072.1995.10472469"
"8364167","Opioid dependency and T-helper cell functions in rhesus monkey","Chuang LF, Killam KF Jr, Chuang RY.","In Vivo. 1993 Mar-Apr;7(2):159-66.","Chuang LF","In Vivo","1993","1993/03/01","","",""
"8360956","From the Food and Drug Administration","Nightingale SL.","JAMA. 1993 Sep 15;270(11):1290. doi: 10.1001/jama.270.11.1290.","Nightingale SL","JAMA","1993","1993/09/15","","","10.1001/jama.270.11.1290"
"8275644","Levomethadyl acetate to be used in narcotic treatment programs","","Clin Pharm. 1993 Nov;12(11):797, 800.","","Clin Pharm","1993","1993/11/01","","",""
"8196570","LAAM--a long-acting methadone for treatment of heroin addiction","","Med Lett Drugs Ther. 1994 Jun 10;36(924):52.","","Med Lett Drugs Ther","1994","1994/06/10","","",""
"8166343","Position statement on methadone maintenance treatment","","Am J Psychiatry. 1994 May;151(5):792-4. doi: 10.1176/ajp.151.5.792.","","Am J Psychiatry","1994","1994/05/01","","","10.1176/ajp.151.5.792"
"8081466","Determination of l-alpha-acetylmethadol, l-alpha-noracetylmethadol and l-alpha-dinoracetylmethadol in plasma by gas chromatography-mass spectrometry","Thomas BF, Jeffcoat AR, Myers MW, Mathews JM, Cook CE.","J Chromatogr B Biomed Appl. 1994 May 13;655(2):201-11. doi: 10.1016/0378-4347(94)00097-2.","Thomas BF","J Chromatogr B Biomed Appl","1994","1994/05/13","","","10.1016/0378-4347(94)00097-2"
"8065777","New therapeutic agents marketed in 1993","Hussar DA.","Pa Med. 1994 Jun;97(6):22-3.","Hussar DA","Pa Med","1994","1994/06/01","","",""
"7931856","Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine","Ling W, Rawson RA, Compton MA.","J Psychoactive Drugs. 1994 Apr-Jun;26(2):119-28. doi: 10.1080/02791072.1994.10472259.","Ling W","J Psychoactive Drugs","1994","1994/04/01","","","10.1080/02791072.1994.10472259"
"7884842","A comprehensive strategy for improving drug abuse treatment","Leshner AI.","J Subst Abuse Treat. 1994 Nov-Dec;11(6):583-6. doi: 10.1016/0740-5472(94)90010-8.","Leshner AI","J Subst Abuse Treat","1994","1994/11/01","","","10.1016/0740-5472(94)90010-8"
"7884149","Toxicological evaluation of mu-agonists. Part I: Assessment of toxicity following 30 days of repeated oral dosing of male and female rats with levo-alpha-acetylmethadol HCl (LAAM)","Borzelleca JF, Egle JL Jr, Harris LS, Johnson DN, Terrill JB, Belleville JA.","J Appl Toxicol. 1994 Nov-Dec;14(6):435-46. doi: 10.1002/jat.2550140609.","Borzelleca JF","J Appl Toxicol","1994","1994/11/01","","","10.1002/jat.2550140609"
"7880038","Biological correlates of methadone maintenance pharmacotherapy","Kreek MJ.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:9-14.","Kreek MJ","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7880010","[Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal]","Patricio LD, Miguel N.","Ann Med Interne (Paris). 1994 Nov;145 Suppl 3:28-30.","Patricio LD","Ann Med Interne (Paris)","1994","1994/11/01","","",""
"7780813","[Current status and prospectives of combating addiction of heroin]","Yang G.","Zhonghua Yi Xue Za Zhi. 1995 Mar;75(3):132.","Yang G","Zhonghua Yi Xue Za Zhi","1995","1995/03/01","","",""
"7668149","SIV mutations detected in morphine-treated Macaca mulatta following SIVmac239 infection","Chuang RY, Chuang LF, Li Y, Kung HF, Killam KF Jr.","Adv Exp Med Biol. 1995;373:175-81. doi: 10.1007/978-1-4615-1951-5_24.","Chuang RY","Adv Exp Med Biol","1995","1995/01/01","","","10.1007/978-1-4615-1951-5_24"
"7514974","Managing illicit drug use. A practical guide","Wodak A.","Drugs. 1994 Mar;47(3):446-57. doi: 10.2165/00003495-199447030-00005.","Wodak A","Drugs","1994","1994/03/01","","","10.2165/00003495-199447030-00005"
"7463351","The effects of levo-alpha-acetylmethadol and its metabolites on schedule-controlled behavior in the pigeon","McGivney WT, McMillan DE.","J Pharmacol Exp Ther. 1981 Feb;216(2):299-305.","McGivney WT","J Pharmacol Exp Ther","1981","1981/02/01","","",""
"7460765","Immunoglobulin levels in heroin addicts after treatment with methadone and methadyl acetate","Matsuyama SS, Charuvastra VC, Ouren J, Schwartz J, Jarvik L.","Drug Alcohol Depend. 1980 Nov;6(5):345-8. doi: 10.1016/0376-8716(80)90200-8.","Matsuyama SS","Drug Alcohol Depend","1980","1980/11/01","","","10.1016/0376-8716(80)90200-8"
"7460760","Follow-up study of subjects on methadyl acetate and methadone","Charuvastra VC, Panell J, Ling W, Ouren J.","Drug Alcohol Depend. 1980 Nov;6(5):273-84. doi: 10.1016/0376-8716(80)90195-7.","Charuvastra VC","Drug Alcohol Depend","1980","1980/11/01","","","10.1016/0376-8716(80)90195-7"
"7457647","A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction","Marcovici M, O'Brien CP, McLellan AT, Kacian J.","Am J Psychiatry. 1981 Feb;138(2):234-6. doi: 10.1176/ajp.138.2.234.","Marcovici M","Am J Psychiatry","1981","1981/02/01","","","10.1176/ajp.138.2.234"
"7452485","Stereospecific radioimmunoassay of alpha-l-acetylmethadol (LAAM)","McGilliard KL, Olsen GD.","J Pharmacol Exp Ther. 1980 Oct;215(1):205-12.","McGilliard KL","J Pharmacol Exp Ther","1980","1980/10/01","","",""
"7448349","Pharmacokinetics of acetylmethadols I: gas-liquid chromatographic determination of L-alpha-acetylmethadol and its major metabolites in plasma","Tse FL, Welling PG.","Biopharm Drug Dispos. 1980 Apr-Jun;1(4):203-9. doi: 10.1002/bdd.2510010408.","Tse FL","Biopharm Drug Dispos","1980","1980/04/01","","","10.1002/bdd.2510010408"
"7441502","Comparative study of the electroencephalographic and behavioral effects of l-alpha-acetylmethadol (LAAM), two of its metabolites and morphine and methadone in the rat","Lukas SE, Moreton JE, Khazan N.","J Pharmacol Exp Ther. 1980 Nov;215(2):382-9.","Lukas SE","J Pharmacol Exp Ther","1980","1980/11/01","","",""
"7406654","A cooperative clinical study of methadyl acetate. II. Friday-only regimen","Ling W, Klett JC, Gillis RD.","Arch Gen Psychiatry. 1980 Aug;37(8):908-11. doi: 10.1001/archpsyc.1980.01780210066006.","Ling W","Arch Gen Psychiatry","1980","1980/08/01","","","10.1001/archpsyc.1980.01780210066006"
"7392057","Success and failure of LAAM maintenance: selected case studies","Tyler J, Hargreaves WA, Weinberg JA.","J Psychedelic Drugs. 1980 Jan-Mar;12(1):41-6. doi: 10.1080/02791072.1980.10471550.","Tyler J","J Psychedelic Drugs","1980","1980/01/01","","","10.1080/02791072.1980.10471550"
"7365687","Enterohepatic circulation of l-alpha-acetylmethadol in the rat","Roerig DL, Hasegawa AT, Wang RI.","J Pharmacol Exp Ther. 1980 May;213(2):284-8.","Roerig DL","J Pharmacol Exp Ther","1980","1980/05/01","","",""
"7357808","The naloxone test for opiate dependence","Judson BA, Himmelberger DU, Goldstein A.","Clin Pharmacol Ther. 1980 Apr;27(4):492-501. doi: 10.1038/clpt.1980.69.","Judson BA","Clin Pharmacol Ther","1980","1980/04/01","","","10.1038/clpt.1980.69"
"7352852","Heroin and chromosome damage","Falek A, Hollingsworth F.","Arch Gen Psychiatry. 1980 Feb;37(2):227-8. doi: 10.1001/archpsyc.1980.01780150117012.","Falek A","Arch Gen Psychiatry","1980","1980/02/01","","","10.1001/archpsyc.1980.01780150117012"
"7352850","Restabilization with methadone after methadyl acetate maintenance","Ling W, Blakis M, Holmes ED, Klett CJ, Carter WE.","Arch Gen Psychiatry. 1980 Feb;37(2):194-6. doi: 10.1001/archpsyc.1980.01780150084009.","Ling W","Arch Gen Psychiatry","1980","1980/02/01","","","10.1001/archpsyc.1980.01780150084009"
"7327086","A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts","Freedman RR, Czertko G.","Drug Alcohol Depend. 1981 Nov;8(3):215-22. doi: 10.1016/0376-8716(81)90064-8.","Freedman RR","Drug Alcohol Depend","1981","1981/11/01","","","10.1016/0376-8716(81)90064-8"
"7308987","Acute effects of ethanol on hepatic uptake and distribution of narcotics in the isolated perfused rabbit liver","Kreek MJ, Rothschild MA, Oratz M, Mongelli J, Handley AC.","Hepatology. 1981 Sep-Oct;1(5):419-23. doi: 10.1002/hep.1840010509.","Kreek MJ","Hepatology","1981","1981/09/01","","","10.1002/hep.1840010509"
"7255458","l-alpha-Acetylmethadol (LAAM) attenuates sympathetic function by a peripheral mechanism","Stickney JL, Eikenburg DC, Keedy JD.","Proc West Pharmacol Soc. 1981;24:237-9.","Stickney JL","Proc West Pharmacol Soc","1981","1981/01/01","","",""
"7217329","Determination of acetylmethadol and metabolites by use of high-performance liquid chromatography","Kiang CH, Campos-Flor S, Inturrisi CE.","J Chromatogr. 1981 Jan 2;222(1):81-93. doi: 10.1016/s0378-4347(00)81035-x.","Kiang CH","J Chromatogr","1981","1981/01/02","","","10.1016/s0378-4347(00)81035-x"
"7213402","Sex and age dependence of the ""selective"" induction of rat hepatic microsomal epoxide hydratase following trans-stilbene oxide, l-alpha-acetylmethadol, or phenobarbital treatment","Gontovnick LS, Bellward GD.","Biochem Pharmacol. 1980 Dec;29(24):3245-51. doi: 10.1016/0006-2952(80)90298-1.","Gontovnick LS","Biochem Pharmacol","1980","1980/12/01","","","10.1016/0006-2952(80)90298-1"
"7199573","Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat","Lukas SE, Moreton JE, Khazan N.","J Pharmacol Exp Ther. 1982 Mar;220(3):561-7.","Lukas SE","J Pharmacol Exp Ther","1982","1982/03/01","","",""
"7195936","Outcome of pregnancy in rats chronically exposed to 1-alpha-acetylmethadol (LAAM)","Lichtblau L, Sparber SB.","J Pharmacol Exp Ther. 1981 Aug;218(2):303-8.","Lichtblau L","J Pharmacol Exp Ther","1981","1981/08/01","","",""
"7195798","Relapse to morphine self-administration in morphine, methadone, and levo-alpha-acetylmethadol (LAAM) post-addict rats","Steinfels GF, Young GA, Khazan N.","Drug Alcohol Depend. 1981 Apr;7(2):133-9. doi: 10.1016/0376-8716(81)90027-2.","Steinfels GF","Drug Alcohol Depend","1981","1981/04/01","","","10.1016/0376-8716(81)90027-2"
"7195581","Stereotypy and striatal dopamine receptor changes with 1-alpha-acetylmethadol (LAAM)","Langley AE, Kirlangitis J, Lehman T.","Pharmacol Biochem Behav. 1981 May;14(5):753-6. doi: 10.1016/0091-3057(81)90144-1.","Langley AE","Pharmacol Biochem Behav","1981","1981/05/01","","","10.1016/0091-3057(81)90144-1"
"7195447","Morphine challenges in levo-alpha-acetylmethadol (LAAM) post-addict rats","Young GA, Wolf DL, Steinfels GF, Khazan N.","Life Sci. 1981 Mar 30;28(13):1523-7. doi: 10.1016/0024-3205(81)90385-4.","Young GA","Life Sci","1981","1981/03/30","","","10.1016/0024-3205(81)90385-4"
"7195069","Prenatal withdrawal from opiates interferes with hatching of otherwise viable chick fetuses","Kuwahara MD, Sparber SB.","Science. 1981 May 22;212(4497):945-7. doi: 10.1126/science.7195069.","Kuwahara MD","Science","1981","1981/05/22","","","10.1126/science.7195069"
"7195068","Opiate withdrawal in utero increases neonatal morbidity in the rat","Lichtblau L, Sparber SB.","Science. 1981 May 22;212(4497):943-5. doi: 10.1126/science.7195068.","Lichtblau L","Science","1981","1981/05/22","","","10.1126/science.7195068"
"7195033","Effects of narcotic abstinence on schedule-controlled behavior in dependent rats","Steinfels GF, Young GA.","Pharmacol Biochem Behav. 1981 Mar;14(3):393-5. doi: 10.1016/0091-3057(81)90407-x.","Steinfels GF","Pharmacol Biochem Behav","1981","1981/03/01","","","10.1016/0091-3057(81)90407-x"
"7192369","A method for determining cumulative behavioral toxicity after chronic oral administration of l-alpha-acetylmethadol to female rats","Lichtblau L, Burklund KE, Sparber SB.","Neurobehav Toxicol. 1980 Spring;2(1):13-9.","Lichtblau L","Neurobehav Toxicol","1980","1980/01/01","","",""
"7190706","Narcotic abstinence in dependent rats: EEG and behavioral correlates","Young GA, Steinfels GF, Khazan N.","Pharmacol Biochem Behav. 1980 Jul;13(1):115-9. doi: 10.1016/0091-3057(80)90129-x.","Young GA","Pharmacol Biochem Behav","1980","1980/07/01","","","10.1016/0091-3057(80)90129-x"
"7181582","Cardiac and autonomic nervous system effects of L-alphacetylmethadol (LAAM)","Langley AE, Lehman TM, Kirlangitis J, Zeid R.","Arch Int Pharmacodyn Ther. 1982 Oct;259(2):250-8.","Langley AE","Arch Int Pharmacodyn Ther","1982","1982/10/01","","",""
"7177308","Congenital behavioral effects in mature rats prenatally exposed to levo-alpha-acetylmethadol (LAAM)","Lichtblau L, Sparber SB.","Neurobehav Toxicol Teratol. 1982 Sep-Oct;4(5):557-65.","Lichtblau L","Neurobehav Toxicol Teratol","1982","1982/09/01","","",""
"7166139","Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers","Judson BA, Goldstein A.","Drug Alcohol Depend. 1982 Oct-Nov;10(2-3):269-82. doi: 10.1016/0376-8716(82)90021-7.","Judson BA","Drug Alcohol Depend","1982","1982/10/01","","","10.1016/0376-8716(82)90021-7"
"7104014","Hepatic glutathione and hepatotoxicity: effects of cytochrome P-450 complexing compounds SKF 525-A, L-alpha acetylmethadol (LAAM), norLAAM, and piperonyl butoxide","James RC, Harbison RD.","Biochem Pharmacol. 1982 May 15;31(10):1829-35. doi: 10.1016/0006-2952(82)90484-1.","James RC","Biochem Pharmacol","1982","1982/05/15","","","10.1016/0006-2952(82)90484-1"
"7099352","Behavioral consequences of embryonic or early postnatal exposure to l-alpha-noracetylmethadol (NLAAM) in the domestic chicken","Kuwahara MD, Sparber SB.","Neurobehav Toxicol Teratol. 1982 May-Jun;4(3):323-9.","Kuwahara MD","Neurobehav Toxicol Teratol","1982","1982/05/01","","",""
"7098447","Plasma and urine disposition of 1-alpha-acetylmethadol and its principal metabolites in man","Finkle BS, Jennison TA, Chinn DM, Ling W, Holmes ED.","J Anal Toxicol. 1982 Mar-Apr;6(2):100-5. doi: 10.1093/jat/6.2.100.","Finkle BS","J Anal Toxicol","1982","1982/03/01","","","10.1093/jat/6.2.100"
"7084024","Heroin addict responses to six weeks of detoxification with LAAM","Sorensen JL, Hargreaves WA, Weinberg JA.","Drug Alcohol Depend. 1982 Feb;9(1):79-87. doi: 10.1016/0376-8716(82)90027-8.","Sorensen JL","Drug Alcohol Depend","1982","1982/02/01","","","10.1016/0376-8716(82)90027-8"
"7070211","Cumulation of active metabolites of levo-alpha-acetylmethadol in the rat fetus and neonate","Lichtblau L, Finkle BS, Sparber SB.","Life Sci. 1982 Jan 18;30(3):307-12. doi: 10.1016/0024-3205(82)90513-6.","Lichtblau L","Life Sci","1982","1982/01/18","","","10.1016/0024-3205(82)90513-6"
"7065831","Withdrawal from heroin in three or six weeks. Comparison of methadyl acetate and methadone","Sorensen JL, Hargreaves WA, Weinberg JA.","Arch Gen Psychiatry. 1982 Feb;39(2):167-71. doi: 10.1001/archpsyc.1982.04290020033007.","Sorensen JL","Arch Gen Psychiatry","1982","1982/02/01","","","10.1001/archpsyc.1982.04290020033007"
"7020527","Clinical status of methadyl acetate (LAAM)","Blaine JD, Renault PR, Thomas DB, Whysner JA.","Ann N Y Acad Sci. 1981;362:101-15. doi: 10.1111/j.1749-6632.1981.tb12797.x.","Blaine JD","Ann N Y Acad Sci","1981","1981/01/01","","","10.1111/j.1749-6632.1981.tb12797.x"
"6992151","Isotope dilution technique for the estimation of l-alpha-[2-3H]-acetylmethadol and its metabolites in biological samples","Man M, Harris LS, Woods LA, Martin BR.","Pharmacology. 1980;20(3):130-6. doi: 10.1159/000137356.","Man M","Pharmacology","1980","1980/01/01","","","10.1159/000137356"
"6989579","Possible influence of opioid normetabolites on the onset, magnitude and quality of the opioid abstinence syndrome","Fraser HF, Gorodetzky CW, Kay DC, Yeh SY.","Drug Alcohol Depend. 1980 Apr;5(4):255-72. doi: 10.1016/0376-8716(80)90002-2.","Fraser HF","Drug Alcohol Depend","1980","1980/04/01","","","10.1016/0376-8716(80)90002-2"
"6888168","Postnatal abstinence or acute toxicity can account for morbidity in developmental studies with opiates","Sparber SB, Lichtblau L.","Life Sci. 1983 Sep 19;33(12):1135-40. doi: 10.1016/0024-3205(83)90017-6.","Sparber SB","Life Sci","1983","1983/09/19","","","10.1016/0024-3205(83)90017-6"
"6811936","LAAM instead of take-home methadone","Resnick RB, Washton AM, Garwood J, Perzel J.","NIDA Res Monogr. 1982 Apr;41:473-5.","Resnick RB","NIDA Res Monogr","1982","1982/04/01","","",""
"6811913","Withdrawal from heroin in three or six weeks: comparison of LAAM versus methadone","Sorensen JL, Hargreaves WA, Weinberg JA.","NIDA Res Monogr. 1982 Apr;41:230-1.","Sorensen JL","NIDA Res Monogr","1982","1982/04/01","","",""
"6808626","Altered respiratory control in newborn puppies after chronic prenatal exposure to alpha-1-acetylmethadol (LAAM)","McGillkiard KL, Jones SE, Robertson GE, Olsen GD.","Respir Physiol. 1982 Mar;47(3):299-311. doi: 10.1016/0034-5687(82)90059-7.","McGillkiard KL","Respir Physiol","1982","1982/03/01","","","10.1016/0034-5687(82)90059-7"
"6785783","Effects of levo-alpha-acetylmethadol (LAAM) on morphine self-administration in the rat","Lukas SE, Moreton JE, Khazan N.","Psychopharmacology (Berl). 1981;73(1):12-6. doi: 10.1007/BF00431092.","Lukas SE","Psychopharmacology (Berl)","1981","1981/01/01","","","10.1007/BF00431092"
"6772759","Pharmacokinetics and metabolism of l-alpha-[O,O'-3H2]-acetyl normethadol (nor-LAAM), the active metabolite of LAAM, in acutely and chronically treated rhesus monkeys","Misra AL, Bartolomeo JG, Bloch R, Mulé SJ, Bates TR.","J Pharmacol Exp Ther. 1980 Sep;214(3):599-607.","Misra AL","J Pharmacol Exp Ther","1980","1980/09/01","","",""
"6752050","Evaluation of clinic attendance schedules for LAAM and methadone: a controlled study","Karp-Gelernter E, Savage C, McCabe OL.","Int J Addict. 1982 Jul;17(5):805-13. doi: 10.3109/10826088209056328.","Karp-Gelernter E","Int J Addict","1982","1982/07/01","","","10.3109/10826088209056328"
"6728871","Modification of drug effects by l-alpha-acetylmethadol","McMillan DE, Brocco M.","Pharmacol Biochem Behav. 1984 Apr;20(4):543-6. doi: 10.1016/0091-3057(84)90302-2.","McMillan DE","Pharmacol Biochem Behav","1984","1984/04/01","","","10.1016/0091-3057(84)90302-2"
"6723548","L-alpha-acetylmethadol-induced tissue alterations in mice","James RC, Freeman RW, Harbison RD.","Drug Chem Toxicol. 1984;7(1):91-112. doi: 10.3109/01480548409014175.","James RC","Drug Chem Toxicol","1984","1984/01/01","","","10.3109/01480548409014175"
"6709095","[Pharmacotherapeutic aspects of aid to heroin addicts]","Fraenkel HM, van Ree JM.","Ned Tijdschr Geneeskd. 1984 Feb 11;128(6):257-9.","Fraenkel HM","Ned Tijdschr Geneeskd","1984","1984/02/11","","",""
"6705455","Plasma testosterone and luteinizing hormone levels during levo-alpha-acetylmethadol maintenance and withdrawal","Mendelson JH, Ellingboe J, Judson BA, Goldstein A.","Clin Pharmacol Ther. 1984 Apr;35(4):545-7. doi: 10.1038/clpt.1984.75.","Mendelson JH","Clin Pharmacol Ther","1984","1984/04/01","","","10.1038/clpt.1984.75"
"6684201","Separation of hepatic N-demethylase-inducing and opioid dependence-producing doses of levo-alpha-acetylmethadol in the pregnant rat","Mercurio SD, Lichtblau L, Sparber SB.","Life Sci. 1983 Sep 19;33(12):1127-34. doi: 10.1016/0024-3205(83)90016-4.","Mercurio SD","Life Sci","1983","1983/09/19","","","10.1016/0024-3205(83)90016-4"
"6681649","Opiate withdrawal increases ornithine decarboxylase activity which is otherwise unaltered in brains of dependent chicken fetuses","Kuwahara MD, Sparber SB.","Life Sci. 1983 Jan 31;32(5):495-502. doi: 10.1016/0024-3205(83)90143-1.","Kuwahara MD","Life Sci","1983","1983/01/31","","","10.1016/0024-3205(83)90143-1"
"6671416","(--)-alpha-Acetylmethadol effects on alcohol and diazepam use, sexual function and cardiac function","Hargreaves WA, Tyler J, Weinberg JA, Sorensen JL, Benowitz N.","Drug Alcohol Depend. 1983 Dec;12(4):323-32. doi: 10.1016/0376-8716(83)90003-0.","Hargreaves WA","Drug Alcohol Depend","1983","1983/12/01","","","10.1016/0376-8716(83)90003-0"
"6647506","Effects of heroin, methadone, LAAM and cyclazocine on acquisition and performance of response sequences in monkeys","Moerschbaecher JM, Thompson DM, Winsauer PJ.","Pharmacol Biochem Behav. 1983 Oct;19(4):701-10. doi: 10.1016/0091-3057(83)90348-9.","Moerschbaecher JM","Pharmacol Biochem Behav","1983","1983/10/01","","","10.1016/0091-3057(83)90348-9"
"6633793","Effects of N-LAAM on [3H]etorphine binding in neuronal-enriched cell cultures","Gibson DA, Vernadakis A.","Neurochem Res. 1983 Sep;8(9):1197-202. doi: 10.1007/BF00964933.","Gibson DA","Neurochem Res","1983","1983/09/01","","","10.1007/BF00964933"
"6617466","Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM)","Judson BA, Goldstein A.","Drug Alcohol Depend. 1983 Jun;11(3-4):271-8. doi: 10.1016/0376-8716(83)90018-2.","Judson BA","Drug Alcohol Depend","1983","1983/06/01","","","10.1016/0376-8716(83)90018-2"
"6539412","Neonatal opiate withdrawal alters the reactivity of adult rats to the hot-plate","Lichtblau L, Messing RB, Sparber SB.","Life Sci. 1984 Apr 30;34(18):1725-30. doi: 10.1016/0024-3205(84)90571-x.","Lichtblau L","Life Sci","1984","1984/04/30","","","10.1016/0024-3205(84)90571-x"
"6479015","Naltrexone treatment of heroin addiction: one-year follow-up","Judson BA, Goldstein A.","Drug Alcohol Depend. 1984 Jul;13(4):357-65. doi: 10.1016/0376-8716(84)90003-6.","Judson BA","Drug Alcohol Depend","1984","1984/07/01","","","10.1016/0376-8716(84)90003-6"
"6463046","Dopaminergic and cholinergic muscarinic receptor effects of L-alphacetylmethadol (LAAM) and its metabolites","Langley AE, Smith SG, Zeid RL.","Proc Soc Exp Biol Med. 1984 Sep;176(4):350-5. doi: 10.3181/00379727-176-41882.","Langley AE","Proc Soc Exp Biol Med","1984","1984/09/01","","","10.3181/00379727-176-41882"
"6455284","Genetic screening of compounds used in drug abuse treatment. III. LAAM","Brusick D, Matheson D, Jagannath D, Braude M, Brockman H, Hung C.","Drug Chem Toxicol. 1981;4(1):19-35. doi: 10.3109/01480548109066369.","Brusick D","Drug Chem Toxicol","1981","1981/01/01","","","10.3109/01480548109066369"
"6442762","Various factors which affect the rate of development of tolerance and physical dependence to abused drugs","Dewey WL.","NIDA Res Monogr. 1984;54:39-49.","Dewey WL","NIDA Res Monogr","1984","1984/01/01","","",""
"6410279","Methadone maintenance: an update","Senay EC.","NIDA Res Monogr. 1983 Apr;43:51-8.","Senay EC","NIDA Res Monogr","1983","1983/04/01","","",""
"6410265","Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy","Hough G, Washton AM, Resnick RB.","NIDA Res Monogr. 1983 Apr;43:302-9.","Hough G","NIDA Res Monogr","1983","1983/04/01","","",""
"6365017","Alternative induction and crossover schedules for methadyl acetate","Ling W, Dorus W, Hargreaves WA, Resnick R, Senay E, Tuason VB.","Arch Gen Psychiatry. 1984 Feb;41(2):193-9. doi: 10.1001/archpsyc.1984.01790130089012.","Ling W","Arch Gen Psychiatry","1984","1984/02/01","","","10.1001/archpsyc.1984.01790130089012"
"6355070","Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects","Washton AM, Resnick RB, Geyer G.","J Clin Psychiatry. 1983 Sep;44(9):335-7.","Washton AM","J Clin Psychiatry","1983","1983/09/01","","",""
"6347117","Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification","Judson BA, Goldstein A, Inturrisi CE.","Arch Gen Psychiatry. 1983 Aug;40(8):834-40. doi: 10.1001/archpsyc.1983.01790070024003.","Judson BA","Arch Gen Psychiatry","1983","1983/08/01","","","10.1001/archpsyc.1983.01790070024003"
"6268789","Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists","Lattin DL, Caviness B, Hudson RG, Greene DL, Raible PK, Richardson JB.","J Med Chem. 1981 Jul;24(7):903-6. doi: 10.1021/jm00139a030.","Lattin DL","J Med Chem","1981","1981/07/01","","","10.1021/jm00139a030"
"6268422","Acetylmethadol metabolites influence opiate receptors and adenylate cyclase in amygdala","Walczak SA, Makman MH, Gardner EL.","Eur J Pharmacol. 1981 Jul 10;72(4):343-9. doi: 10.1016/0014-2999(81)90573-2.","Walczak SA","Eur J Pharmacol","1981","1981/07/10","","","10.1016/0014-2999(81)90573-2"
"6196651","Prenatal levo-alpha-acetylmethadol (LAAM) and/or naloxone: effects on brain chemistry and postweaning behavior","Lichtblau L, Sparber SB.","Neurobehav Toxicol Teratol. 1983 Jul-Aug;5(4):479-86.","Lichtblau L","Neurobehav Toxicol Teratol","1983","1983/07/01","","",""
"6171394","Continuous exposure of the chick embryo to l-alpha-noracetylmethadol does not alter brain protein or nucleic acid content","Kuwahara MD, Sparber SB.","Dev Pharmacol Ther. 1981;3(1):12-24. doi: 10.1159/000457417.","Kuwahara MD","Dev Pharmacol Ther","1981","1981/01/01","","","10.1159/000457417"
"6166807","Peripheral sympatholytic effects of 1-alpha-acetylmethadol","Stickney JL, Eikenburg DC.","J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):369-80. doi: 10.1097/00005344-198103000-00014.","Stickney JL","J Cardiovasc Pharmacol","1981","1981/03/01","","","10.1097/00005344-198103000-00014"
"6156685","Binding of 1-alpha-acetylmethadol and its metabolites to blood constituents","Toro-Goyco E.","Biochem Pharmacol. 1980 Jul 1;29(13):1897-902. doi: 10.1016/0006-2952(80)90100-8.","Toro-Goyco E","Biochem Pharmacol","1980","1980/07/01","","","10.1016/0006-2952(80)90100-8"
"6156472","Zinc tannate salts of heroin, LAAM and hydromorphone attenuate opiate withdrawal syndrome","Brands B, Baskerville JC, Hirst M, Gowdey CW.","Psychopharmacology (Berl). 1980;68(3):311-4. doi: 10.1007/BF00428122.","Brands B","Psychopharmacology (Berl)","1980","1980/01/01","","","10.1007/BF00428122"
"6151173","[Treatment of opiate withdrawal syndromes (historical review)]","Jeziorski K, Matsumoto H.","Pol Tyg Lek. 1984 Oct 22;39(43):1433-6.","Jeziorski K","Pol Tyg Lek","1984","1984/10/22","","",""
"6144496","The influence of sex steroid status on the induction of rat hepatic aniline hydroxylase and ethylmorphine demethylase activities by L-alpha-acetylmethadol","Beierschmitt WP, Lesher GA, Weiner M.","Drug Metab Dispos. 1984 Mar-Apr;12(2):266-8.","Beierschmitt WP","Drug Metab Dispos","1984","1984/03/01","","",""
"6140153","(-)-alpha-Acetylmethadol for treatment of chronic pain patients who abuse opioids","Tennant FS Jr.","Drug Alcohol Depend. 1983 Nov;12(3):243-7. doi: 10.1016/0376-8716(83)90066-2.","Tennant FS Jr","Drug Alcohol Depend","1983","1983/11/01","","","10.1016/0376-8716(83)90066-2"
"6138224","Uptake of l-alpha-acetylmethadol (LAAM) and its analgesically active metabolites, nor-LAAM and dinor-LAAM, in the isolated perfused rat lung","Roerig DL, Dahl RR, Dawson CA, Wang RI.","Drug Metab Dispos. 1983 Sep-Oct;11(5):411-6.","Roerig DL","Drug Metab Dispos","1983","1983/09/01","","",""
"6125355","Uptake and efflux of 1-alpha-acetylmethadol (LAAM) and methadone in the isolated perfused rat lung","Roerig DL, Dawson CA, Wang RI.","Drug Metab Dispos. 1982 May-Jun;10(3):230-5.","Roerig DL","Drug Metab Dispos","1982","1982/05/01","","",""
"6124388","Effects of perinatal exposure of Wistar rats to l-alpha-acetylmethadol.HCl on hepatic microsomal mixed-function oxidase enzyme activity in the adult","Finlayson MJ, Bellward GD.","Drug Metab Dispos. 1982 Jan-Feb;10(1):74-6.","Finlayson MJ","Drug Metab Dispos","1982","1982/01/01","","",""
"6110254","Occurrence of corneal opacities in rats after acute administration of l-alpha-acetylmethadol","Roerig DL, Hasegawa AT, Harris GJ, Lynch KL, Wang RI.","Toxicol Appl Pharmacol. 1980 Nov;56(2):155-63. doi: 10.1016/0041-008x(80)90285-9.","Roerig DL","Toxicol Appl Pharmacol","1980","1980/11/01","","","10.1016/0041-008x(80)90285-9"
"6109016","Comparative cardiac contractile actions of six narcotic analgesics: morphine, meperidine, pentazocine, fentanyl, methadone and l-alpha-acetylmethadol (LAAM)","Rendig SV, Amsterdam EA, Henderson GL, Mason DT.","J Pharmacol Exp Ther. 1980 Oct;215(1):259-65.","Rendig SV","J Pharmacol Exp Ther","1980","1980/10/01","","",""
"6103787","Distribution of l-alpha-[2-3H]acetylmethadol and its metabolites in maternal and fetal rat tissues","Man M, Alozie SO, Woods LA, Martin BR, Harris LS.","Drug Metab Dispos. 1980 Mar-Apr;8(2):55-9.","Man M","Drug Metab Dispos","1980","1980/03/01","","",""
"4066875","Quantitation of l-alpha-acetylmethadol and its metabolites in human serum by capillary gas-liquid chromatography and nitrogen detection","Verebey K, DePace A, Mulé SJ.","J Chromatogr. 1985 Oct 11;343(2):339-48. doi: 10.1016/s0378-4347(00)84602-2.","Verebey K","J Chromatogr","1985","1985/10/11","","","10.1016/s0378-4347(00)84602-2"
"4009444","Effect of phenobarbital pretreatment on the plasma and urinary levels of (-)-alpha-acetylmethadol and its metabolites","Kuttab SH, Nowshad F, Shargel L.","J Pharm Sci. 1985 Mar;74(3):331-4. doi: 10.1002/jps.2600740323.","Kuttab SH","J Pharm Sci","1985","1985/03/01","","","10.1002/jps.2600740323"
"3929318","Acetylmethadol versus methadone: human mood and motility","Crowley TJ, Macdonald MJ, Wagner JE, Zerbe G.","Psychopharmacology (Berl). 1985;86(4):458-63. doi: 10.1007/BF00427908.","Crowley TJ","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00427908"
"3923521","Variability in simian motor and social behavior with alternating-day acetylmethadol","Crowley TJ, Macdonald MJ, Zerbe G.","Psychopharmacology (Berl). 1985;85(3):353-60. doi: 10.1007/BF00428201.","Crowley TJ","Psychopharmacology (Berl)","1985","1985/01/01","","","10.1007/BF00428201"
"3908338","Methadone maintenance treatment","Senay EC.","Int J Addict. 1985 Jun-Jul;20(6-7):803-21. doi: 10.3109/10826088509047754.","Senay EC","Int J Addict","1985","1985/06/01","","","10.3109/10826088509047754"
"3806733","Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM)","Tennant FS Jr, Rawson RA, Pumphrey E, Seecof R.","J Subst Abuse Treat. 1986;3(3):195-202. doi: 10.1016/0740-5472(86)90021-8.","Tennant FS Jr","J Subst Abuse Treat","1986","1986/01/01","","","10.1016/0740-5472(86)90021-8"
"3229587","In vivo carcinogenesis assay of L-alpha-acetylmethadol.HCl in rodents","Rosenkrantz H, Fleischman RW.","Fundam Appl Toxicol. 1988 Nov;11(4):626-39. doi: 10.1016/0272-0590(88)90126-1.","Rosenkrantz H","Fundam Appl Toxicol","1988","1988/11/01","","","10.1016/0272-0590(88)90126-1"
"3092073","How effective is LAAM treatment? Clinical comparison with methadone","Zangwell BC, McGahan P, Dorozynsky L, McLellan AT.","NIDA Res Monogr. 1986;67:249-55.","Zangwell BC","NIDA Res Monogr","1986","1986/01/01","","",""
"2986161","Neurotoxicity of opiates during brain development: in vivo and in vitro studies","Vernadakis A, Gibson A.","Prog Clin Biol Res. 1985;163C:245-53.","Vernadakis A","Prog Clin Biol Res","1985","1985/01/01","","",""
"2898216","Divided dose for methadone maintenance patients","Walton RG.","Am J Psychiatry. 1988 Jul;145(7):904. doi: 10.1176/ajp.145.7.904a.","Walton RG","Am J Psychiatry","1988","1988/07/01","","","10.1176/ajp.145.7.904a"
"2894961","l-alpha-Acetylmethadol administration to lactating rat dams. Effect on hepatic aniline hydroxylase and ethylmorphine N-demethylase activities in rat pups","Lesher GA, Beierschmitt WP.","Drug Metab Dispos. 1988 Jan-Feb;16(1):9-14.","Lesher GA","Drug Metab Dispos","1988","1988/01/01","","",""
"2867050","Pharmacological advances in addiction treatment","Preston KL, Bigelow GE.","Int J Addict. 1985 Jun-Jul;20(6-7):845-67. doi: 10.3109/10826088509047756.","Preston KL","Int J Addict","1985","1985/06/01","","","10.3109/10826088509047756"
"2641056","NIDA's Medication Development Program--1989","Schuster CR, Snyder M.","NIDA Res Monogr. 1989;95:64-73.","Schuster CR","NIDA Res Monogr","1989","1989/01/01","","",""
"2619421","L-alphacetylmethadol (LAAM) effects on cardiac muscarinic receptors","Langley AE.","Arch Int Pharmacodyn Ther. 1989 Jul-Aug;300:140-8.","Langley AE","Arch Int Pharmacodyn Ther","1989","1989/07/01","","",""
"2471291","Depression of hepatic glutathione by opioid analgesic drugs in mice","Skoulis NP, James RC, Harbison RD, Roberts SM.","Toxicol Appl Pharmacol. 1989 Jun 1;99(1):139-47. doi: 10.1016/0041-008x(89)90119-1.","Skoulis NP","Toxicol Appl Pharmacol","1989","1989/06/01","","","10.1016/0041-008x(89)90119-1"
"2197054","Clinical toxicology of drugs used in the treatment of opiate dependency","Fraser AD.","Clin Lab Med. 1990 Jun;10(2):375-86.","Fraser AD","Clin Lab Med","1990","1990/06/01","","",""
"1445673","Absolute configuration of (-)-alpha-acetylmethadol hydrochloride","Flippen-Anderson JL, George C.","Acta Crystallogr C. 1992 Oct 15;48 ( Pt 10):1855-7. doi: 10.1107/s0108270192001409.","Flippen-Anderson JL","Acta Crystallogr C","1992","1992/10/15","","","10.1107/s0108270192001409"
"1261171","Effects of acetylmethadol on plasma testosterone","Mendelson JH, Inturrisi CE, Renault P, Senay EC.","Clin Pharmacol Ther. 1976 Mar;19(3):371-4. doi: 10.1002/cpt1976193371.","Mendelson JH","Clin Pharmacol Ther","1976","1976/03/01","","","10.1002/cpt1976193371"
"1255420","Rapid TLC determination of methadyl acetate and some in vitro metabolites","Kochhar MM, Hamrick ME, Bavda LT.","J Pharm Sci. 1976 Jan;65(1):137-8. doi: 10.1002/jps.2600650134.","Kochhar MM","J Pharm Sci","1976","1976/01/01","","","10.1002/jps.2600650134"
"1237140","Stereotypy following acute administration of l-alpha-acetylmethadol (LAAM) in the rat","Henderson GL, Westkaemper R.","Proc West Pharmacol Soc. 1975;18:204-7.","Henderson GL","Proc West Pharmacol Soc","1975","1975/01/01","","",""
"1227302","Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program","Schecter A, Kauders F.","Am J Drug Alcohol Abuse. 1975;2(3-4):443-9. doi: 10.3109/00952997509005668.","Schecter A","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005668"
"1227295","LAAM (l-alpha-acetylmethadol) study in St. Louis","Parwatikar S, Crawford J, Unverdi C.","Am J Drug Alcohol Abuse. 1975;2(3-4):341-52. doi: 10.3109/00952997509005659.","Parwatikar S","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005659"
"1227294","Methadone and l-alpha-acetylmethadol in a treatment program in Brooklyn","Schecter A, Kauders F.","Am J Drug Alcohol Abuse. 1975;2(3-4):331-9. doi: 10.3109/00952997509005658.","Schecter A","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005658"
"1227293","l-alpha-acetylmethadol and methadone in Buffalo: safety and efficacy","Taintor Z, Hough G, Plumb M, Murphy BF.","Am J Drug Alcohol Abuse. 1975;2(3-4):317-30. doi: 10.3109/00952997509005657.","Taintor Z","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005657"
"1227292","Implementing a national study of a new maintenance drug","Newmann MC, Klett CJ, Stillman R.","Am J Drug Alcohol Abuse. 1975;2(3-4):289-300. doi: 10.3109/00952997509005654.","Newmann MC","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005654"
"1227291","On the role of chemotherapy in the treatment of heroin addiction","Goldstein A.","Am J Drug Alcohol Abuse. 1975;2(3-4):279-88. doi: 10.3109/00952997509005653.","Goldstein A","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005653"
"1215653","Duration of antinociceptive action of morphine, methadone and alpha-l-acetylmethadol subcutaneously in rats","Wax J, McLean JR, Tessman DK, McCarthy DA, Nuite JA.","Res Commun Chem Pathol Pharmacol. 1975 Dec;12(4):613-20.","Wax J","Res Commun Chem Pathol Pharmacol","1975","1975/12/01","","",""
"1178682","Renal toxicity of l-alpha-acetylmethadol (LAAM) in the rat","Rosenkranz RP, Henderson GL.","Proc West Pharmacol Soc. 1975;18:284-7.","Rosenkranz RP","Proc West Pharmacol Soc","1975","1975/01/01","","",""
"1151981","Synthesis of alpha-1-noracetylmethadol. A facile N-demethylation of alpha-1-acetylmethadol","Chatterjie N, Inturrisi CE.","J Med Chem. 1975 Jun;18(6):630-1. doi: 10.1021/jm00240a024.","Chatterjie N","J Med Chem","1975","1975/06/01","","","10.1021/jm00240a024"
"1150818","Simultaneous determination of acetylmethadol and its active riotransformation products in human biofluids","Kaiko RF, Chatterjie N, Inturrisi CE.","J Chromatogr. 1975 Jun 18;109(2):247-58. doi: 10.1016/s0021-9673(01)91796-0.","Kaiko RF","J Chromatogr","1975","1975/06/18","","","10.1016/s0021-9673(01)91796-0"
"1088897","1-Acetylmethadol (LAM) treatment of opiate dependence: plasma and urine levels of two pharmacologically active metabolites, 1974","Billings RE, McMahon RE, Blake DA.","NIDA Res Monogr. 1976 Jul;(8):54.","Billings RE","NIDA Res Monogr","1976","1976/07/01","","",""
"1071365","Interactions of narcotics, narcotic antagonists, and ethanol during acute, chronic, and withdrawal states","Ho AK, Chen RC.","Ann N Y Acad Sci. 1976;281:297-310. doi: 10.1111/j.1749-6632.1976.tb27940.x.","Ho AK","Ann N Y Acad Sci","1976","1976/01/01","","","10.1111/j.1749-6632.1976.tb27940.x"
"1032578","Failure of acetylmethadol in treatment of narcotic addicts due to nonpharmacologic factors","Segal R, Everson A, Sellers EM, Thakur R.","Can Med Assoc J. 1976 Nov 20;115(10):1014-6.","Segal R","Can Med Assoc J","1976","1976/11/20","PMC1878880","",""
"1025033","The use of l-alpha-acetylmethadol in treatment of heroin addiction: an open study","Wilson BK, Spannagel V, Thomson CP.","Int J Addict. 1976;11(6):1091-100. doi: 10.3109/10826087609058831.","Wilson BK","Int J Addict","1976","1976/01/01","","","10.3109/10826087609058831"
"1002792","Comparative study on the derivatization of l-alpha-acetyl-methadol metabolites for electron capture gas-liquid chromatography","Lau DH, Henderson GL.","J Chromatogr. 1976 Dec 22;129:329-38. doi: 10.1016/s0021-9673(00)87792-4.","Lau DH","J Chromatogr","1976","1976/12/22","","","10.1016/s0021-9673(00)87792-4"
"995185","Levomethadyl in maintenance treatment of opiate dependence. 1972 [proceedings]","Zaks A, Fink M, Freedman AM.","NIDA Res Monogr. 1976 Jul;(8):92-3.","Zaks A","NIDA Res Monogr","1976","1976/07/01","","",""
"995184","Levomethadyl acetate: prolonged duration of opioid effects, including cross tolerance to heroin, in man. 1973 [proceedings]","Levine R, Zaks A, Fink M, Freedman AM.","NIDA Res Monogr. 1976 Jul;(8):84-5.","Levine R","NIDA Res Monogr","1976","1976/07/01","","",""
"995183","Disposition of acetylmethadol in relation to pharmacological activity. 1975 [proceedings]","Kaiki RF, Inturrisi C.","NIDA Res Monogr. 1976 Jul;(8):80-1.","Kaiki RF","NIDA Res Monogr","1976","1976/07/01","","",""
"995182","Simultaneous determination of acetyl-methadol and its active biotransformation products in human biofluids. 1975 [proceedings]","Kaiki RF, Chatterjie N, Inturrisi CE.","NIDA Res Monogr. 1976 Jul;(8):79.","Kaiki RF","NIDA Res Monogr","1976","1976/07/01","","",""
"995181","Pharmacodynamics of LAAM in man: plasma levels of LAAM and its metabolites following acute and chronic administration in man (fourth and sixth quarter progress reports). 1974-5 [proceedings]","Henderson GL.","NIDA Res Monogr. 1976 Jul;(8):64-5.","Henderson GL","NIDA Res Monogr","1976","1976/07/01","","",""
"995180","LAAM and LAAM metabolites: plasma levels in patients. Summary progress report. 1975 [proceedings]","Goldstein A.","NIDA Res Monogr. 1976 Jul;(8):61.","Goldstein A","NIDA Res Monogr","1976","1976/07/01","","",""
"995179","Actions and addiction liabilities of alpha-acetylmethadols in man. 1952 [proceedings]","Fraser HF, Isbell H.","NIDA Res Monogr. 1976 Jul;(8):58-2.","Fraser HF","NIDA Res Monogr","1976","1976/07/01","","",""
"995178","1-Alpha-acetylmethadol (LAM): comparison of laboratory findings, electroencephalograms, and Cornell Medical Index of patients stabilized on LAM with those on methadone. 1972 [proceedings]","Blachly PH, David NA, Irwin S.","NIDA Res Monogr. 1976 Jul;(8):57.","Blachly PH","NIDA Res Monogr","1976","1976/07/01","","",""
"995177","1-Alpha-acetylmethoadol in the treatment of opiate addiction: progress report. 1971 [proceedings]","Blachly PH.","NIDA Res Monogr. 1976 Jul;(8):55-6.","Blachly PH","NIDA Res Monogr","1976","1976/07/01","","",""
"995176","A clinical experience with LAAM","Goldstein A.","NIDA Res Monogr. 1976 Jul;(8):115-7.","Goldstein A","NIDA Res Monogr","1976","1976/07/01","","",""
"995175","The chemistry of LAAM","Archer S.","NIDA Res Monogr. 1976 Jul;(8):10-3.","Archer S","NIDA Res Monogr","1976","1976/07/01","","",""
"978303","Synthesis of (-)-alpha-acetylmethadol metabolites and related compounds","Carroll FI, Brine GA, Chen T, Kohl DW, Welch CD.","J Org Chem. 1976 Oct 29;41(22):3521-4. doi: 10.1021/jo00884a006.","Carroll FI","J Org Chem","1976","1976/10/29","","","10.1021/jo00884a006"
"942010","Therapeutic effects of methadone and 1-alpha-acetylmethadol","Karp-Gelernter E, Wurmser L, Savage C.","Am J Psychiatry. 1976 Aug;133(8):955-7. doi: 10.1176/ajp.133.8.955.","Karp-Gelernter E","Am J Psychiatry","1976","1976/08/01","","","10.1176/ajp.133.8.955"
"937573","l-Alpha-acetylmethadol (LAAM): prognostic considerations","Resnick RB, Orlin L, Geyer G, Schuyten-Resnick E, Kestenbaum RS, Freedman AM.","Am J Psychiatry. 1976 Jul;133(7):814-9. doi: 10.1176/ajp.133.7.814.","Resnick RB","Am J Psychiatry","1976","1976/07/01","","","10.1176/ajp.133.7.814"
"935974","Pharmacotherapy of opiate addiction","Swanson DA.","S Afr Med J. 1976 May 22;50(22):857-9.","Swanson DA","S Afr Med J","1976","1976/05/22","","",""
"928944","The effect of alpha-1-acetylmethadol hydrochloride on rat hepatic aryl hydrocarbon hydroxylase and epoxide hydrase","Bellward GD, Li M, Lopaschuk GD, Warren P.","Res Commun Chem Pathol Pharmacol. 1977 Nov;18(3):415-22.","Bellward GD","Res Commun Chem Pathol Pharmacol","1977","1977/11/01","","",""
"909070","Effect of alteration of metabolism on the analgesic activity, toxicity, distribution and excretion of l-alpha-acetylmethadol in the rat","Roerig DL, Hasegawa AT, Wang RI.","J Pharmacol Exp Ther. 1977 Nov;203(2):377-87.","Roerig DL","J Pharmacol Exp Ther","1977","1977/11/01","","",""
"896857","Brain levels of l-alpha--acetylmethadol (LAAM) and metabolites in the rat: correlation with pharmacological effects","Skrumsager BK, Henderson GL.","Proc West Pharmacol Soc. 1977;20:473-6.","Skrumsager BK","Proc West Pharmacol Soc","1977","1977/01/01","","",""
"894527","Calcium antagonist activity of methadone, l-acetylmethadol and l-pentazocine in the rat aortic strip","Lee CH, Berkowitz BA.","J Pharmacol Exp Ther. 1977 Sep;202(3):646-53.","Lee CH","J Pharmacol Exp Ther","1977","1977/09/01","","",""
"880978","Inhibition of growth in young mice treated with d,1-methadone","Smith AA, Hui FW, Crofford MJ.","Eur J Pharmacol. 1977 Jun 15;43(4):307-14. doi: 10.1016/0014-2999(77)90036-x.","Smith AA","Eur J Pharmacol","1977","1977/06/15","","","10.1016/0014-2999(77)90036-x"
"879977","Failure of methadone and levomethadyl acetate (levo-alpha-acetylmethadol, LAAM) maintenance to affect memory","Grevert P, Masover B, Goldstein A.","Arch Gen Psychiatry. 1977 Jul;34(7):849-53. doi: 10.1001/archpsyc.1977.01770190111011.","Grevert P","Arch Gen Psychiatry","1977","1977/07/01","","","10.1001/archpsyc.1977.01770190111011"
"872883","Inotropic effects of 1-alpha-acetylmethadol (LAAM)","Stickney JL.","Eur J Pharmacol. 1977 Jun 1;43(3):289-92. doi: 10.1016/0014-2999(77)90031-0.","Stickney JL","Eur J Pharmacol","1977","1977/06/01","","","10.1016/0014-2999(77)90031-0"
"867429","Cardiac effects of 1-alpha-acetylmethadol. I. Chronotropic effects in vitro","Stickney JL.","Toxicol Appl Pharmacol. 1977 Apr;40(1):23-32. doi: 10.1016/0041-008x(77)90112-0.","Stickney JL","Toxicol Appl Pharmacol","1977","1977/04/01","","","10.1016/0041-008x(77)90112-0"
"853115","Simultaneous determination of acetylmethadol and its major metabolites by gas-liquid chromatography","Tse FL, Welling PG.","J Chromatogr. 1977 May 11;135(1):205-7. doi: 10.1016/s0021-9673(00)86320-7.","Tse FL","J Chromatogr","1977","1977/05/11","","","10.1016/s0021-9673(00)86320-7"
"847284","Metabolism and probable active metabolite of alpha-l-acetylmethadol in rat","Kochhar MM, Davidson PP, Bhushan RS.","Res Commun Chem Pathol Pharmacol. 1977 Feb;16(2):251-63.","Kochhar MM","Res Commun Chem Pathol Pharmacol","1977","1977/02/01","","",""
"832446","Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration","Henderson GL, Wilson BK, Lau DH.","Clin Pharmacol Ther. 1977 Jan;21(1):16-25. doi: 10.1002/cpt197721116.","Henderson GL","Clin Pharmacol Ther","1977","1977/01/01","","","10.1002/cpt197721116"
"828467","Evaluation of narcotic and narcotic antagonist interactions in primates","Killam KF Jr, Brocco MJ, Robinson CA.","Ann N Y Acad Sci. 1976;281:331-5. doi: 10.1111/j.1749-6632.1976.tb27943.x.","Killam KF Jr","Ann N Y Acad Sci","1976","1976/01/01","","","10.1111/j.1749-6632.1976.tb27943.x"
"828465","Disposition of narcotics and narcotic antagonists","Inturrisi CE.","Ann N Y Acad Sci. 1976;281:273-87. doi: 10.1111/j.1749-6632.1976.tb27938.x.","Inturrisi CE","Ann N Y Acad Sci","1976","1976/01/01","","","10.1111/j.1749-6632.1976.tb27938.x"
"825782","Pharmacology of LAAM","Archer S.","NIDA Res Monogr. 1976 Jul;(8):15-28.","Archer S","NIDA Res Monogr","1976","1976/07/01","","",""
"818895","1-alpha-acetylmethadol(LAAM) pharmacokinetics and metabolism: current status","Misra AL, Mulé SJ.","Am J Drug Alcohol Abuse. 1975;2(3-4):301-5. doi: 10.3109/00952997509005655.","Misra AL","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005655"
"792709","Summary of Veterans Administration Phase II cooperative study for LAAM and methadone","Ling W, Charuvastra VC, Kaim SC, Klett CJ.","NIDA Res Monogr. 1976 Jul;(8):94-102.","Ling W","NIDA Res Monogr","1976","1976/07/01","","",""
"792708","Three times a week LAAM equals seven times a week methadone: a preliminary report of a control study. 1974 [proceedings]","Senay EC, Renault PF, Dimenza S, Collier WE, Daniels SJ, Dorus W.","NIDA Res Monogr. 1976 Jul;(8):90-1.","Senay EC","NIDA Res Monogr","1976","1976/07/01","","",""
"792707","A 48-week study of methadone, methadyl acetate, and minimal services. 1974 [proceedings]","Senay EC, Jaffe JH, Dimenza S, Renault PF.","NIDA Res Monogr. 1976 Jul;(8):88-9.","Senay EC","NIDA Res Monogr","1976","1976/07/01","","",""
"792706","A methadone/1-alpha-acetylmethadol (LAAM) maintenance study [proceedings]","Savage C, Karp E, Curran S.","NIDA Res Monogr. 1976 Jul;(8):86-7.","Savage C","NIDA Res Monogr","1976","1976/07/01","","",""
"792705","The use of 1-alpha-acetyl-methadol (LAAM) as compared to methadone in the maintenance and detoxification of young heroin addicts. 1973 [proceedings]","Lehmann WX.","NIDA Res Monogr. 1976 Jul;(8):82-3.","Lehmann WX","NIDA Res Monogr","1976","1976/07/01","","",""
"792704","Methadyl acetate vs methadione: a double-blind study in heroin users. 1972 [proceedings]","Jaffe JH, Senay EC, Schuster CR, Renault PF, Smith B, Dimenza S.","NIDA Res Monogr. 1976 Jul;(8):76-8.","Jaffe JH","NIDA Res Monogr","1976","1976/07/01","","",""
"792703","Methadone and 1-methadyl acetate: use in management of narcotic addicts. 1971 [proceedings]","Jaffe JH, Senay EC.","NIDA Res Monogr. 1976 Jul;(8):74-5.","Jaffe JH","NIDA Res Monogr","1976","1976/07/01","","",""
"792702","Comparison of acetylmethadol and methadone in the treatment of long-term heroin users: a pilot study. 1973 [proceedings]","Jaffe JH, Schuster CR, Smith BB, Blachly PH.","NIDA Res Monogr. 1976 Jul;(8):72-3.","Jaffe JH","NIDA Res Monogr","1976","1976/07/01","","",""
"792701","Acute time-dose-response effects of cyclazocine, methadone, and methadyl in man. 1975 [proceedings]","Irwin S, Kinohi RG, Cooler PM, Bottomly DR.","NIDA Res Monogr. 1976 Jul;(8):70-1.","Irwin S","NIDA Res Monogr","1976","1976/07/01","","",""
"792700","Preliminary observations with acute and chronic methadone and 1-alpha-acetylmethadol administration in humans","Irwin S, Blachly P, Marks J, Carter CC.","NIDA Res Monogr. 1976 Jul;(8):68-9.","Irwin S","NIDA Res Monogr","1976","1976/07/01","","",""
"792699","The behavioral, cognitive and physiologic effects of long-term methadone and methadyl treatment. 1973 [proceedings]","Irwin S, Blachly PH, Marks J, Carlson E, Loewen J, Reade N.","NIDA Res Monogr. 1976 Jul;(8):66-7.","Irwin S","NIDA Res Monogr","1976","1976/07/01","","",""
"792698","Can the community be protected against the hazards of take-home methadone? 1974 [proceedings]","Goldstein A, Judson B.","NIDA Res Monogr. 1976 Jul;(8):62-3.","Goldstein A","NIDA Res Monogr","1976","1976/07/01","","",""
"792697","Toxicology of LAAM","Wolven A, Archer S.","NIDA Res Monogr. 1976 Jul;(8):29-38.","Wolven A","NIDA Res Monogr","1976","1976/07/01","","",""
"792696","LAAM bibliography: clinical","","NIDA Res Monogr. 1976 Jul;(8):123-6.","","NIDA Res Monogr","1976","1976/07/01","","",""
"792695","LAAM bibliography: preclinical","","NIDA Res Monogr. 1976 Jul;(8):118-22.","","NIDA Res Monogr","1976","1976/07/01","","",""
"792694","Phase III clinical study of levo-alpha-acetylmethadol","Whysner JA.","NIDA Res Monogr. 1976 Jul;(8):109-11.","Whysner JA","NIDA Res Monogr","1976","1976/07/01","","",""
"792693","Summary of SAODAP Phase II cooperative study of LAAM vs. methadone","Ling W, Klett CJ, Gillis RD.","NIDA Res Monogr. 1976 Jul;(8):103-8.","Ling W","NIDA Res Monogr","1976","1976/07/01","","",""
"792692","Introduction. Roc: 3x/week LAAM: alternative to methadone","Blaine J, Renault P.","NIDA Res Monogr. 1976 Jul;(8):1-9.","Blaine J","NIDA Res Monogr","1976","1976/07/01","","",""
"779705","Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study","Ling W, Charuvastra C, Kaim SC, Klett CJ.","Arch Gen Psychiatry. 1976 Jun;33(6):709-20. doi: 10.1001/archpsyc.1976.01770060043007.","Ling W","Arch Gen Psychiatry","1976","1976/06/01","","","10.1001/archpsyc.1976.01770060043007"
"776522","Methadone/LAAM maintenance: a comparison study","Savage C, Karp EG, Curran SF, Hanlon TE, McCabe OL.","Compr Psychiatry. 1976 May-Jun;17(3):415-24. doi: 10.1016/0010-440x(76)90044-4.","Savage C","Compr Psychiatry","1976","1976/05/01","","","10.1016/0010-440x(76)90044-4"
"775968","Current status of the evaluation of LAAM as a maintenance drug for heroin addicts","Ling W, Charuvastra VC, Klett CJ.","Am J Drug Alcohol Abuse. 1975;2(3-4):307-15. doi: 10.3109/00952997509005656.","Ling W","Am J Drug Alcohol Abuse","1975","1975/01/01","","","10.3109/00952997509005656"
"759091","A computer feedback system for clinical research","Wood W, Youatt R.","Comput Programs Biomed. 1979 Jan;9(1):80-94. doi: 10.1016/0010-468x(79)90021-7.","Wood W","Comput Programs Biomed","1979","1979/01/01","","","10.1016/0010-468x(79)90021-7"
"747734","[OH]- negative chemical ionization mass spectrometry. Reactions of [OH]- with methadone, l-alpha-acetylmethadol and their metabolites","Smit AL, Field FH.","Biomed Mass Spectrom. 1978 Oct;5(10):572-5. doi: 10.1002/bms.1200051004.","Smit AL","Biomed Mass Spectrom","1978","1978/10/01","","","10.1002/bms.1200051004"
"727887","A cooperative clinical study of methadyl acetate. I. Three-times-a-week regimen","Ling W, Klett CJ, Gillis RD.","Arch Gen Psychiatry. 1978 Mar;35(3):345-53. doi: 10.1001/archpsyc.1978.01770270095009.","Ling W","Arch Gen Psychiatry","1978","1978/03/01","","","10.1001/archpsyc.1978.01770270095009"
"714970","Interaction toxicity between ethanol and narcotics in mice with reference to alpha-1-acetylmethadol (LAAM)","Ho AK, Chen RC, Ho CC.","Pharmacol Biochem Behav. 1978 Aug;9(2):195-200. doi: 10.1016/0091-3057(78)90164-8.","Ho AK","Pharmacol Biochem Behav","1978","1978/08/01","","","10.1016/0091-3057(78)90164-8"
"702312","Mass fragmentographic determination of methadyl acetate in urine using stable isotope labeled analog as internal standard","Jindal SP, Vestergaard P, Lutz T.","J Pharm Sci. 1978 Oct;67(10):1483-5. doi: 10.1002/jps.2600671048.","Jindal SP","J Pharm Sci","1978","1978/10/01","","","10.1002/jps.2600671048"
"693557","levo-Alpha-acetylmethadol and metabolites: some effects on schedule-controlled behavior in the rat","Aigner TG, Ford RD, Balster RL.","Pharmacol Biochem Behav. 1978 Jun;8(6):735-7. doi: 10.1016/0091-3057(78)90274-5.","Aigner TG","Pharmacol Biochem Behav","1978","1978/06/01","","","10.1016/0091-3057(78)90274-5"
"684742","Cardiac effects of 1-alpha-acetylmethadol. IV. Mechanism of inotropic effects","Stickney JL.","Toxicol Appl Pharmacol. 1978 Jun;44(3):471-9. doi: 10.1016/0041-008x(78)90255-7.","Stickney JL","Toxicol Appl Pharmacol","1978","1978/06/01","","","10.1016/0041-008x(78)90255-7"
"678048","Chromosomes in patients receiving methadone and methadyl acetate","Matsuyama SS, Charuvastra VC, Jarvik LF, Fu TK, Sanders K, Yen FS.","Arch Gen Psychiatry. 1978 Aug;35(8):989-91. doi: 10.1001/archpsyc.1978.01770320083007.","Matsuyama SS","Arch Gen Psychiatry","1978","1978/08/01","","","10.1001/archpsyc.1978.01770320083007"
"674263","Behavioral effects of chronic oral administration of levo-alpha-acetylmethadol in the rat","Agner TG, Balster RL.","Pharmacol Biochem Behav. 1978 May;8(5):593-6. doi: 10.1016/0091-3057(78)90393-3.","Agner TG","Pharmacol Biochem Behav","1978","1978/05/01","","","10.1016/0091-3057(78)90393-3"
"663393","Microsomal enzyme induction following repeated oral administration of LAAM","Masten LW, Price SR, Burnett CJ.","Res Commun Chem Pathol Pharmacol. 1978 Apr;20(1):1-20.","Masten LW","Res Commun Chem Pathol Pharmacol","1978","1978/04/01","","",""
"660544","Uptake, metabolism and efflux of l-alpha-acetylmethadol (LAAM) by rat lung tissue","Lau DH, Henderson GL.","J Pharmacol Exp Ther. 1978 Jul;206(1):143-50.","Lau DH","J Pharmacol Exp Ther","1978","1978/07/01","","",""
"637626","Effect of autonomic blocking agents on chronotropic actions of 1-alpha-acetylmethadol","Stickney JL.","Arch Int Pharmacodyn Ther. 1978 Jan;231(1):70-80.","Stickney JL","Arch Int Pharmacodyn Ther","1978","1978/01/01","","",""
"637619","Effect of 1-alpha-acetylmethadol (LAAM) on various physiological parameters in the conscious dog","Waters IW, Catravas JD, Guinn MM, Davis WM.","Arch Int Pharmacodyn Ther. 1978 Jan;231(1):157-67.","Waters IW","Arch Int Pharmacodyn Ther","1978","1978/01/01","","",""
"634227","LAAM--a long-acting methadone","","Med Lett Drugs Ther. 1978 Apr 21;20(8):40.","","Med Lett Drugs Ther","1978","1978/04/21","","",""
"631012","Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts","Trueblood B, Judson BA, Goldstein A.","Drug Alcohol Depend. 1978 Mar;3(2):125-32. doi: 10.1016/0376-8716(78)90025-x.","Trueblood B","Drug Alcohol Depend","1978","1978/03/01","","","10.1016/0376-8716(78)90025-x"
"591140","Problems of methadone diversion and implications for control","Resnick RB.","Int J Addict. 1977 Oct;12(7):803-6. doi: 10.3109/10826087709027250.","Resnick RB","Int J Addict","1977","1977/10/01","","","10.3109/10826087709027250"
"575854","Women on LAAM maintenance: initial experiences","Hargreaves WA, Ling W, Brown TC, Weinberg JA, Landsberg R, Harrison WL.","J Psychedelic Drugs. 1979 Jul-Sep;11(3):223-9. doi: 10.1080/02791072.1979.10472108.","Hargreaves WA","J Psychedelic Drugs","1979","1979/07/01","","","10.1080/02791072.1979.10472108"
"574449","Development of cellular tolerance to lethality and analgesia concurrent with physical dependence following repeated oral administration of LAAM","Masten LW.","Drug Alcohol Depend. 1979 Sep;4(5):381-90. doi: 10.1016/0376-8716(79)90070-x.","Masten LW","Drug Alcohol Depend","1979","1979/09/01","","","10.1016/0376-8716(79)90070-x"
"568189","Tolerance and cross tolerance to toxic effects of morphine, methadone and 1-alpha-acetylmethadol (LAAM) in naive and morphine dependent rats","Chiba S, Moreton EJ, Khazan N.","Jpn J Pharmacol. 1978 Jun;28(3):498-501. doi: 10.1254/jjp.28.498.","Chiba S","Jpn J Pharmacol","1978","1978/06/01","","","10.1254/jjp.28.498"
"546625","Effects observed during subchronic administration of l-alpha-acetylmethadol (LAAM) to guinea pigs","Keedy JD, Stickney JL.","Drug Chem Toxicol. 1979;2(3):237-44. doi: 10.3109/01480547908998245.","Keedy JD","Drug Chem Toxicol","1979","1979/01/01","","","10.3109/01480547908998245"
"533680","Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization","Judson BA, Goldstein A.","Drug Alcohol Depend. 1979 Nov;4(6):461-6. doi: 10.1016/0376-8716(79)90024-3.","Judson BA","Drug Alcohol Depend","1979","1979/11/01","","","10.1016/0376-8716(79)90024-3"
"533679","Effectiveness of psychotherapeutic counseling in methadone maintenance","Desmond DP.","Drug Alcohol Depend. 1979 Nov;4(6):439-47. doi: 10.1016/0376-8716(79)90022-x.","Desmond DP","Drug Alcohol Depend","1979","1979/11/01","","","10.1016/0376-8716(79)90022-x"
"530266","Narcotics and rat testicular metabolism","Jakubovic A, McGeer EG.","Mol Pharmacol. 1979 Nov;16(3):970-80.","Jakubovic A","Mol Pharmacol","1979","1979/11/01","","",""
"524375","Cardiac effects of 1-alpha-acetylmethadol. V. Possible involvement of the autonomic nervous system","Eikenburg DC, Stickney JL.","Toxicol Appl Pharmacol. 1979 Oct;51(1):91-100. doi: 10.1016/0041-008x(79)90011-5.","Eikenburg DC","Toxicol Appl Pharmacol","1979","1979/10/01","","","10.1016/0041-008x(79)90011-5"
"517492","Measurement of urine temperature as an alternative to observed urination in a narcotic treatment program","Judson BA, Himmelberger DU, Goldstein A.","Am J Drug Alcohol Abuse. 1979;6(2):197-205. doi: 10.3109/00952997909007045.","Judson BA","Am J Drug Alcohol Abuse","1979","1979/01/01","","","10.3109/00952997909007045"
"499734","Cardiac effects of 1-alpha-acetylmethadol (LAAM) in different species","Stickney JL, Keedy JD.","Gen Pharmacol. 1979;10(5):359-62. doi: 10.1016/0306-3623(79)90070-3.","Stickney JL","Gen Pharmacol","1979","1979/01/01","","","10.1016/0306-3623(79)90070-3"
"491858","Naloxone-precipitated jumping in mice pretreated with acute injections of opioids","Wiley JN, Downs DA.","Life Sci. 1979 Aug 27;25(9):797-801. doi: 10.1016/0024-3205(79)90525-3.","Wiley JN","Life Sci","1979","1979/08/27","","","10.1016/0024-3205(79)90525-3"
"491835","Modification of hepatic microsomal oxidative drug metabolism in rats by the opiate maintenance drugs acetylmethadol, propoxyphene, and methadone","Roberts SM, Franklin MR.","Life Sci. 1979 Sep 3;25(10):845-51. doi: 10.1016/0024-3205(79)90542-3.","Roberts SM","Life Sci","1979","1979/09/03","","","10.1016/0024-3205(79)90542-3"
"479337","The quantitative analysis of 1-alpha-acetylmethadol and its principal metabolites in biological specimens by gas chromatography-chemical ionization-multiple ion monitoring mass spectrometry","Jennison TA, Finkle BS, Chinn DM, Crouch DJ.","J Chromatogr Sci. 1979 Feb;17(2):64-74. doi: 10.1093/chromsci/17.2.64.","Jennison TA","J Chromatogr Sci","1979","1979/02/01","","","10.1093/chromsci/17.2.64"
"467958","Anti-cholinesterase activity of 1-alpha-acetylmethadol: relationship to bradycardia","Eikenburg DC, Stickney JL.","Gen Pharmacol. 1979;10(3):195-200. doi: 10.1016/0306-3623(79)90089-2.","Eikenburg DC","Gen Pharmacol","1979","1979/01/01","","","10.1016/0306-3623(79)90089-2"
"461484","Discriminative stimulus properties of levo-alpha-acetylmethadol and its metabolites","Holtzman SG.","Pharmacol Biochem Behav. 1979 Apr;10(4):565-8. doi: 10.1016/0091-3057(79)90234-x.","Holtzman SG","Pharmacol Biochem Behav","1979","1979/04/01","","","10.1016/0091-3057(79)90234-x"
"450937","The effects of acetylmethadol on motor activity and schedule-controlled responding","Mcgivney WT, McMillan DE.","Pharmacol Biochem Behav. 1979 Feb;10(2):261-5. doi: 10.1016/0091-3057(79)90098-4.","Mcgivney WT","Pharmacol Biochem Behav","1979","1979/02/01","","","10.1016/0091-3057(79)90098-4"
"417622","Severe toxicity and lethality in some monkeys following chronic administration of levo-alpha-acetylmethadol (LAAM)","Misra AL, Mule SJ.","Am J Drug Alcohol Abuse. 1977;4(3):431-40. doi: 10.3109/00952997709002776.","Misra AL","Am J Drug Alcohol Abuse","1977","1977/01/01","","","10.3109/00952997709002776"
"415198","Self-administration of heroin, acetylmethadol, morphine, and methadone in rhesus monkeys","Harrigan SE, Downs DA.","Life Sci. 1978 Feb;22(7):619-23. doi: 10.1016/0024-3205(78)90342-9.","Harrigan SE","Life Sci","1978","1978/02/01","","","10.1016/0024-3205(78)90342-9"
"410055","Head-shake distributions during self-maintained dependence on morphine, methadone, and l-alpha-acetylmethadol (LAAM) in the rat","Chiba S, Young GA, Moreton JE, Khazan N.","Psychopharmacology (Berl). 1977 Aug 31;54(1):105-7. doi: 10.1007/BF00426549.","Chiba S","Psychopharmacology (Berl)","1977","1977/08/31","","","10.1007/BF00426549"
"409895","Chronic effects of acetylmethadol and methadone in rhesus monkeys","Downs DA, Thomas DJ, Braude MC.","Life Sci. 1977 Sep 1;21(5):719-26. doi: 10.1016/0024-3205(77)90081-9.","Downs DA","Life Sci","1977","1977/09/01","","","10.1016/0024-3205(77)90081-9"
"331052","Methadyl acetate versus methadone: the experience of one hospital","Panell J, Charuvastra VC, Ouren J.","Med J Aust. 1977 Jul 30;2(5):150-2.","Panell J","Med J Aust","1977","1977/07/30","","",""
"318710","Methadyl acetate and methadone. An open comparison","Senay EC, Dorus W, Renault PF.","JAMA. 1977 Jan 10;237(2):138-42.","Senay EC","JAMA","1977","1977/01/10","","",""
"283726","Toward a coherent system of narcotic addiction treatment","Dogoloff LI.","Ann N Y Acad Sci. 1978;311:296-301. doi: 10.1111/j.1749-6632.1978.tb16786.x.","Dogoloff LI","Ann N Y Acad Sci","1978","1978/01/01","","","10.1111/j.1749-6632.1978.tb16786.x"
"283721","Clinical use of LAAM","Blaine JD, Renault P, Levine GL, Whysner JA.","Ann N Y Acad Sci. 1978;311:214-31. doi: 10.1111/j.1749-6632.1978.tb16778.x.","Blaine JD","Ann N Y Acad Sci","1978","1978/01/01","","","10.1111/j.1749-6632.1978.tb16778.x"
"283720","Recent developments in chemotherapy of narcotic addiction. Part VI. LAAM and narcotic antagonists: introductory remarks","Jasinski DR.","Ann N Y Acad Sci. 1978;311:197-8. doi: 10.1111/j.1749-6632.1978.tb16776.x.","Jasinski DR","Ann N Y Acad Sci","1978","1978/01/01","","","10.1111/j.1749-6632.1978.tb16776.x"
"263550","Time-action and behavioral effects of amphetamine, ethanol, and acetylmethadol","Downs DA, Braude MC.","Pharmacol Biochem Behav. 1977 Jun;6(6):671-6. doi: 10.1016/0091-3057(77)90093-4.","Downs DA","Pharmacol Biochem Behav","1977","1977/06/01","","","10.1016/0091-3057(77)90093-4"
"238782","Disposition of acetylmethadol in relation to pharmacologic action","Kaiko RF, Inturrisi CE.","Clin Pharmacol Ther. 1975 Jul;18(1):96-103. doi: 10.1002/cpt197518196.","Kaiko RF","Clin Pharmacol Ther","1975","1975/07/01","","","10.1002/cpt197518196"
"232903","Opioid self-administration and REM sleep EEG power spectra","Steinfels GF, Young GA, Khazan N.","NIDA Res Monogr. 1979;27:114-20.","Steinfels GF","NIDA Res Monogr","1979","1979/01/01","","",""
"228320","Observations on the ""in vitro and in vivo"" inhibition of the cytochrome P-450 multifunctional oxidase","Kraus JL, Yaouanc JJ.","Pharmacol Res Commun. 1979 Jul;11(7):597-604. doi: 10.1016/s0031-6989(79)80031-4.","Kraus JL","Pharmacol Res Commun","1979","1979/07/01","","","10.1016/s0031-6989(79)80031-4"
"225470","Pharmacodynamic profiles of 1-alpha-acetylmethadol (LAAM) and its N-demethylated metabolites, nor-LAAM and dinor-LAAM, during self-administration in the dependent rat","Young GA, Steinfels GF, Khazan N.","J Pharmacol Exp Ther. 1979 Sep;210(3):453-7.","Young GA","J Pharmacol Exp Ther","1979","1979/09/01","","",""
"223173","Spontaneous vs. naloxone-induced abstinence in dependent rats self-administering L-alpha-acetylmethadol (LAAM) or morphine","Young GA, Steinfels GF, Khazan N.","Pharmacol Biochem Behav. 1979 Apr;10(4):585-9. doi: 10.1016/0091-3057(79)90237-5.","Young GA","Pharmacol Biochem Behav","1979","1979/04/01","","","10.1016/0091-3057(79)90237-5"
"211020","Transitional patterns of self-administration following substitution of methadone or l-alpha-acetylmethadol (LAAM) for morphine in dependent rats","Young GA, Steinfels GF, Khazan N.","Drug Alcohol Depend. 1978 Jul;3(4):273-9. doi: 10.1016/0376-8716(78)90081-9.","Young GA","Drug Alcohol Depend","1978","1978/07/01","","","10.1016/0376-8716(78)90081-9"
"192530","1-alpha-acetylmethadol (LAAM), methadone and morphine abstinence in dependent rats: EEG and behavioral correlates","Young GA, Moreton JE, Meltzer LT, Khazan N.","Drug Alcohol Depend. 1977 Mar;2(2):141-8. doi: 10.1016/0376-8716(77)90014-x.","Young GA","Drug Alcohol Depend","1977","1977/03/01","","","10.1016/0376-8716(77)90014-x"
"186810","Use of sepharose-diaminopropyl amino succinyl methadol to isolate narcotic binding activity","Morin AM, Cummins JT.","Proc West Pharmacol Soc. 1976;19:44-7.","Morin AM","Proc West Pharmacol Soc","1976","1976/01/01","","",""
"186713","The use of LAAM in treatment","Cooper J.","NIDA Res Monogr. 1976 Jul;(8):112-4.","Cooper J","NIDA Res Monogr","1976","1976/07/01","","",""
"175076","Extraction method and thin-layer chromatographic system for the determination of alpha-l-acetylmethadol and metabolites in biological fluids","Kuttab SH, North-Root H, Henderson GL.","J Chromatogr. 1976 Feb 4;117(1):193-8. doi: 10.1016/s0021-9673(00)81082-1.","Kuttab SH","J Chromatogr","1976","1976/02/04","","","10.1016/s0021-9673(00)81082-1"
"168214","Estimation of 1-alpha(2-3H)acetylmethadol in biological materials and its separation from some metabolites and congeners on glass fibre sheets","Misra AL, Bloch R, Mulé SJ.","J Chromatogr. 1975 Mar 19;106(1):184-7. doi: 10.1016/s0021-9673(01)81061-x.","Misra AL","J Chromatogr","1975","1975/03/19","","","10.1016/s0021-9673(01)81061-x"
"121364","On the relative efficacy of LAAM and methadone","Whysner JA, Thomas DB, Ling W, Charuvastra C.","NIDA Res Monogr. 1979;27:429-33.","Whysner JA","NIDA Res Monogr","1979","1979/01/01","","",""
"121363","General cardiovascular pharmacology of 1-alpha-acetylmethadol (LAAM)","Stickney JL, Eikenburg DC, Keedy JD.","NIDA Res Monogr. 1979;27:422-8.","Stickney JL","NIDA Res Monogr","1979","1979/01/01","","",""
"121361","The effect of l-alpha acetyl methadol in morphine-dependent rats","Riley AL, Etherton DS, Shapiro RM.","NIDA Res Monogr. 1979;27:409-14.","Riley AL","NIDA Res Monogr","1979","1979/01/01","","",""
"121344","The phase III clinical evaluation of LAAM: I. Comparative epidemiology of mortality in LAAM and methadone","Thomas DB, Whysner JA, Newmann MC.","NIDA Res Monogr. 1979;27:289-295b.","Thomas DB","NIDA Res Monogr","1979","1979/01/01","","",""
"121337","Effects of chronic treatment with morphine, methadone, and LAAM on the response to phencyclidine in rats","Pryor GT, Howd RA.","NIDA Res Monogr. 1979;27:212-8.","Pryor GT","NIDA Res Monogr","1979","1979/01/01","","",""
"119638","Inhibition of the cytochrome P-450 multifunctional oxidase by N-propargyl analogs of SKF-525 A and acetylmethadol","Kraus JL, Yaouanc JJ.","Eur J Drug Metab Pharmacokinet. 1979;4(4):219-24. doi: 10.1007/BF03189430.","Kraus JL","Eur J Drug Metab Pharmacokinet","1979","1979/01/01","","","10.1007/BF03189430"
"117996","Additional metabolic correlates of 1-alpha-acetylmethadol (LAAM)-induced cellular tolerance and physical dependence: the role of the hepatic microsomal electron transport system","Masten LW, Barnes TB.","Drug Alcohol Depend. 1979 Nov;4(6):449-60. doi: 10.1016/0376-8716(79)90023-1.","Masten LW","Drug Alcohol Depend","1979","1979/11/01","","","10.1016/0376-8716(79)90023-1"
"114383","Clinical experiences with repeated oral administration of l-alpha-acetylmethadol (LAAM) in the rhesus monkey","Masten LW, Bedford JA, Guinn MM, Wilson MC.","Drug Chem Toxicol. 1978;1(2):173-90. doi: 10.3109/01480547809034434.","Masten LW","Drug Chem Toxicol","1978","1978/01/01","","","10.3109/01480547809034434"
"111279","Every-other-day acetylmethadol disturbs circadian cycles of human motility","Crowley TJ, Jones RH, Hydinger-Macdonald MJ, Lingle JR, Wagner JE, Egan DJ.","Psychopharmacology (Berl). 1979 Apr 11;62(2):151-5. doi: 10.1007/BF00427129.","Crowley TJ","Psychopharmacology (Berl)","1979","1979/04/11","","","10.1007/BF00427129"
"109865","Interactions of acetylmethadol or methadone with other drugs in rhesus monkeys","Downs DA.","Pharmacol Biochem Behav. 1979 Mar;10(3):407-14. doi: 10.1016/0091-3057(79)90205-3.","Downs DA","Pharmacol Biochem Behav","1979","1979/03/01","","","10.1016/0091-3057(79)90205-3"
"106294","The future of LAAM","Renault PF.","NIDA Res Monogr. 1978;(19):291-3.","Renault PF","NIDA Res Monogr","1978","1978/01/01","","",""
"106293","Phase III clinical study of LAAM: report of current status and analysis of early terminations","Whysner JA, Levine GL.","NIDA Res Monogr. 1978;(19):277-90.","Whysner JA","NIDA Res Monogr","1978","1978/01/01","","",""
"106292","The SAODAP cooperative studies of LAAM: unblinded comparison with methadone","Klett CJ.","NIDA Res Monogr. 1978;(19):271-6.","Klett CJ","NIDA Res Monogr","1978","1978/01/01","","",""
"106291","A U.S. Veterans Administration cooperative study on methadyl acetate","Charuvastra VC.","NIDA Res Monogr. 1978;(19):260-70.","Charuvastra VC","NIDA Res Monogr","1978","1978/01/01","","",""
"106289","Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence","Blaine JD.","NIDA Res Monogr. 1978;(19):249-59.","Blaine JD","NIDA Res Monogr","1978","1978/01/01","","",""
"106288","Levo-alpha-acetylmethadol: new drug for old habits","Ling W.","NIDA Res Monogr. 1978;(19):242-8.","Ling W","NIDA Res Monogr","1978","1978/01/01","","",""
"106287","Multimodality treatment of narcotic addiction: an overview","Woody GE, O'Brien CP, Greenstein R.","NIDA Res Monogr. 1978;(19):226-40.","Woody GE","NIDA Res Monogr","1978","1978/01/01","","",""
"105659","Pharmacology of l-alpha-acetylmethadol (LAAM) in subhuman primates","Mulé SJ, Misra AL.","Ann N Y Acad Sci. 1978;311:199-213. doi: 10.1111/j.1749-6632.1978.tb16777.x.","Mulé SJ","Ann N Y Acad Sci","1978","1978/01/01","","","10.1111/j.1749-6632.1978.tb16777.x"
"101886","Carbon-13 nuclear magnetic resonance study of the alpha- and beta- isomers of methadol and acetylmethadol hydrochlorides","Carroll FI, Moreland CG, Brine GA, Boldt KG.","NIDA Res Monogr. 1978;(22):410-22.","Carroll FI","NIDA Res Monogr","1978","1978/01/01","","",""
"99782","The effect of ethanol on the metabolism of chronically-administered l-alpha-acetylmethadol (LAAM) in the rhesus monkey","Casella GA, Deneau GA, Mule SJ.","Res Commun Chem Pathol Pharmacol. 1978 Aug;21(2):351-4.","Casella GA","Res Commun Chem Pathol Pharmacol","1978","1978/08/01","","",""
"98628","Physiological disposition and biotransformation of l-alpha-[2-3H]acetylmethadol (LAAM) in acutely and chronically treated monkeys","Misra AL, Mulé SJ, Bloch R, Bates TR.","J Pharmacol Exp Ther. 1978 Aug;206(2):475-91.","Misra AL","J Pharmacol Exp Ther","1978","1978/08/01","","",""
"95037","The binding of LAAM and its metabolites to blood constituents","Toro-Goyco E, Martin BR, Harris LS.","NIDA Res Monogr. 1979;27:54-60.","Toro-Goyco E","NIDA Res Monogr","1979","1979/01/01","","",""
"92035","Dependence in rats after one injection of heroin-, LAAM- or hydromorphone-zinc tannate","Brands B, Baskerville JC, Hirst M, Gowdey CW.","Pharmacol Biochem Behav. 1979 Sep;11(3):279-82. doi: 10.1016/0091-3057(79)90135-7.","Brands B","Pharmacol Biochem Behav","1979","1979/09/01","","","10.1016/0091-3057(79)90135-7"
"60774","The binding of the optical isomers of methadone, alpha-methadol, alpha-acetylmethadol and their N-demethylated derivatives to the opiate receptors of rat brain","Horng JS, Smits SE, Wong DT.","Res Commun Chem Pathol Pharmacol. 1976 Aug;14(4):621-9.","Horng JS","Res Commun Chem Pathol Pharmacol","1976","1976/08/01","","",""
"40771","Role of enterohepatic circulation in the analgesic action of 1-alpha-acetylmethadol in the rat","Roerig DL, Hasegawa AT, Wang RI.","Drug Metab Dispos. 1979 Sep-Oct;7(5):306-9.","Roerig DL","Drug Metab Dispos","1979","1979/09/01","","",""
"33587","Recent developments in chemotherapy of narcotic addiction, 3-4 November 1977, Washington, D.C.: proceedings","","Ann N Y Acad Sci. 1978;311:1-315.","","Ann N Y Acad Sci","1978","1978/01/01","","",""
"26496","Behavioral effects of psychotherapeutic agents in rats chronically dosed with alpha-acetylmethadol","Maickel RP, Lambert CS, Braude MC, Zabik JE.","Commun Psychopharmacol. 1978;2(1):45-50.","Maickel RP","Commun Psychopharmacol","1978","1978/01/01","","",""
"24616","New approach to the rehabilitation of the hard core drug addict (heroin methadone addicts) a pilot community study","Serban G.","J Clin Psychiatry. 1978 Feb;39(2):111-6.","Serban G","J Clin Psychiatry","1978","1978/02/01","","",""
"21776","The metabolism of drugs in isolated rat hepatocytes. A comparison with in vivo drug metabolism and drug metabolism in subcellular liver fractions","Billings RE, McMahon RE, Ashmore J, Wagle SR.","Drug Metab Dispos. 1977 Nov-Dec;5(6):518-26.","Billings RE","Drug Metab Dispos","1977","1977/11/01","","",""
"19211","Metabolism and disposition of l-alpha-acetylmethadol in the rat","Henderson GL, North-Root H, Kuttab SH.","Drug Metab Dispos. 1977 Jul-Aug;5(4):321-8.","Henderson GL","Drug Metab Dispos","1977","1977/07/01","","",""
"11419","Use of miotic effect in evaluating analgesic drugs in man. 1954 [proceedings]","Fraser HF, Nash TL, Vanhorn GD, Isbell H.","NIDA Res Monogr. 1976 Jul;(8):60.","Fraser HF","NIDA Res Monogr","1976","1976/07/01","","",""
"11418","Rx: 3x/week LAAM: alternative to methadone. Clinical studies: Phase I","Sollod RM, Goldstein MG.","NIDA Res Monogr. 1976 Jul;(8):39-51.","Sollod RM","NIDA Res Monogr","1976","1976/07/01","","",""
"6726","Pharmacokinetics and metabolism of (-)-alpha-[2-3H]acetylmethadol (LAAM) in the monkey: evidence for a new metabolite","Misra AL, Vardy J, Bloch R, Mulé SJ, Deneau GA.","J Pharm Pharmacol. 1976 Apr;28(4):316-8. doi: 10.1111/j.2042-7158.1976.tb04164.x.","Misra AL","J Pharm Pharmacol","1976","1976/04/01","","","10.1111/j.2042-7158.1976.tb04164.x"
